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ABSTRACT 
 
Quorum sensing bacteria produce and release chemical signal molecules (like N-
acyl homoserine lactones, AHL) that increase in concentration as a function of cell 
density. The responses cover a large spectrum of process such as the virulence in 
Staphylococcus aureus, competence for DNA-uptake in Bacillus subtilis and 
Streptococcus pneumoniae, sporulation in Bacillus subtilis, conjugal plasmid transfer in 
Enterococcus faecalis, and bacteriocin production in lactic acid bacteria. The collapse of 
(AHL) signaling system in bacteria represents an attractive therapeutic approach towards 
the development of new antibiotics.   Recently, a new extracellular modulator was 
isolated from a symbiotic bacterium (Bradyrhizobium japonicum) that nodulates soybean. 
This quorum sensing molecule, containing a novel oxetane ring, was partially 
characterized and named bradyoxetin (2-{4-[[4-(3-aminooxetan-2-
yl)phenyl](imino)methyl]phenyl}oxetan-3-ylamine). The objective of this dissertation 
research was to confirm the absolute stereochemistry of bradyoxetin by total synthesis, 
with the production of the four possible stereoisomers.  Novel chemical strategies for the 
efficient formation of oxetane rings were developed, using the inexpensive chiral drug 
chloramphenicol as a starting material.  Employing a five-step protocol, suitable oxetane 
intermediates were synthesized and characterized as precursors to the final step of 
bradyoxetin synthesis.    Approaches towards the synthesis were also developed for the 
construction of the natural product oxetin.   New scaffolds bearing an oxetane ring were 
created for the future development of new antibiotics. 
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CHAPTER 1:  QUORUM SENSING 
1.1 Introduction to Quorum Sensing 
There is a global consensus that a part of the microbial world that was once 
“under a limited control” is now at the edge of a mass rebellion. The drug arsenal once 
used to control diseases caused by pathogenic bacteria genera such as Staphylococcus, 
Mycobacterium and Streptococcus have become in many instances useless. Bacteria have 
acquired resistance to antibacterial drugs by a variety of mechanisms which include, but 
are not limited to,  the increased ability to degrade anti-bacterial compounds through β-
lactamases (Mansour et al., 2008), decreased permeability (Kumar & Schweizer, 2005), 
decreased affinity for antibiotics (Zapun et al., 2008), and increased efflux (Xian-Zhi & 
Nikaido, 2009) of antibiotics which leaves us with the option of discovering new drugs or 
developing new strategies to circumvent the resistance problem.  
 Cellular communication, whether among nerve cells, or bacteria, happens through 
the complex use of signaling molecules that govern basic cellular activities and 
coordinating cell actions, representing a reasonable target for drug discovery. In bacteria, 
the organization and coordination resembles multi-cellular organisms (Bassler & Losick, 
2006; Ben-Jacob & Levine, 2006) and is referred to as “quorum sensing” (Hentzer & 
Givskov, 2003). Before a necessary and drastic change in the environment occurs there 
must be a minimum concentration of a bacterial population, therefore termed, a quorum. 
The size of the population is sensed by the individuals; in this particular case the cells, 
through chemical signaling. Therefore, the signals used in bacterial language are small 
molecules, sometimes referred as auto-inducers (AIs) (Pomianek & Semmelhack, 2007), 
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or pheromones (Kleerebezem, 1997) released into the environment where they grow 
(Figure 1). Examples of such molecules include acyl-homoserine lactones (1-2) (Parsek 
and Greenberg 2000), diketopiperazines (3-4) (Holden et al., 1999), quinolones (5) (Pesci 
et al., 1999), γ-butyrolactones (6-7) (Chun et al., 1997; Hentzer et al., 2002; Manefield et 
al., 2002) and surprisingly a borate (8) (Xin et al., 2002). 
 
 
Figure 1.  Autoinducer chemotypes. 
 
When the concentration of autoinducers reaches a threshold level perceived by the 
population, it is said that the population is “quorated” (Telford, 1998), which implies that 
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there is a significant number of individuals able to make a behavioral group-base decision 
(de Kievit, 2000). The molecules have to travel either from one cell to another to 
implicate an effective change; cross the cell surface through active transport (Pestova et 
al., 1996) or passive diffusion, and reach a different cell.  The signal producing proteins 
in Gram-positive bacteria are membrane embedded proteins responsible for a double task, 
namely production and secretion of chemical signals (Ishii, 2010). In Gram-negative 
bacteria the cytosolic type Lux-I protein has been identified and belongs to the most 
common and studied route (Williams, 2007). 
Once inside the cell, the signal will have to interact with a receptor which will 
convert the chemical signal into information. This “chemical data” will most likely end 
up as a “genetic instruction” or expressed gene. Different species tend to use different 
sets of molecules for different tasks, but one set of molecules can have antagonistic or 
agonistic response in different species of bacteria. In the previously cellular scenario 
described above there are places for agonistic and antagonistic events. Both can be used 
to elicit a desirable therapeutic response. The interventions can be summarized in seven 
categories: i.) inhibition of auto inducer synthesis; ii.) auto inducer receptor antagonism; 
iii.) inhibition of targets downstream of receptor binding; iv.) sequestration of auto 
inducers by antibodies; v.) degradation of auto inducers performed by either enzymes or 
catalytic antibodies (abzymes); vi.) inhibition of auto inducer transport/secretion and; 
vii.) antagonism of autoinducer’s receptors.  
  Although it is widely believed that quorum sensing has an impact on cellular 
activity, it is not necessary for bacterial survival per se. It can be very useful as an 
adjuvant therapy but quorum sensing molecules lack bactericidal and/or bacteriostatic 
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activity. Quorum sensing been implicated in a wide variety of changes in phenotypes 
including:  secretion of virulence factors (Dong et al., 2001; Lyon & Muir, 2003; Jones et 
al., 2005), biofilm formation (Hentzer et al., 2003; Kaufmann et al., 2006), 
bioluminescence production (Dunlap, 1999; Frezza et al., 2007), conjugation (Vannini et 
al., 2004), sporulation (Varga, 2004), expression of virulence factors (Harraghy et al., 
2007), swarming motility (Gonzalez Barrios et al., 2006) and symbiosis (Rumbaugh, 
2007). 
1.2 Quorum Sensing Pathways and Inhibitors 
 In order to have a better understanding of how quorum sensing can be used to 
manipulate bacterial behavior, it is critical to have a better understanding of quorum 
sensing pathways. There are three pathways that describe interactions among bacteria: 1.) 
the autoinducer peptide (AIP) quorum sensing pathway, 2.) the acyl-homo-serine lactone 
(AHL) quorum sensing pathway and 3.) the autoinducer 2 (AI-2) pathway. 
 The AIP pathway is the most common type of quorum sensing pathway among 
Gram-positive bacteria. The chemical signals used are oligopeptides, which are 
structurally limited to 5-17 amino acids residues and are usually modified post-
translationally with diverse cyclic structures including thiolactones (9) (Mayville et al., 
1999; McDowell et al., 2001), lanthionine (e.g., nisin or subtilin) (Kies et al., 2003; 
Kleerebezem, 2004; Dufour et al., 2007) or isoprenyl groups, as in the case of the unique 
ComX pheromone (10) from Bacillus subtilis (Ansaldi et al., 2002). These functionalities 
are thought to provide binding selectivity and signal specificity in Gram- positive bacteria 
(Figure 2). 
5 
 
 
 
  
 
 
 
 
 
 
Figure 2.  Diverse AIPs:  Thiolactones from Streptoccocus aureus, and 
isoprenoidal ComX from Bacillus subtillis. 
 
The AIPs start their cycle by binding to a receptor on the bacterial surface which 
is part of the two component adaptive system for the detection of autoinducers. These 
two component systems are composed of a sensor and a response regulator protein which 
utilizes phosphorylation for signal status. If the AIP is bound to a receptor, 
phosphorylation of the histidine sensor kinase protein (letter H-Figure 3) occurs. A 
second event uses the phosphoryl group of the histidine kinase for the phosphorylation of 
a conserved aspartate residue (letter D-Figure 3) of a response regulatory protein. The 
response regulatory protein is involved in the synthesis and release on the AIPs, forming 
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a feedback loop control and the expression of number of genes which leads to quorum 
sensing phenotypic responses. The exporting of the AIPs is performed through active 
transport using ATP-binding cassettes (ABCs) which are also responsible for the 
processing of the peptide-pheromone precursors (Ishii, 2010). Once transported out of the 
cell, the peptide-pheromones can interact with another cell or be used by the same cell 
initiating the cycle again. 
 
Figure 3.  Model of quorum sensing that involves peptide pheromones and a 
two component system in Gram-positive bacteria (Kleerebezem, 1997). 
(Permission granted for reproduction). 
 
The other Gram-positive bacteria quorum sensing system have minor, but 
important modifications, including the addition of an accessory gene regulatory system 
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(Agr) (Peng, 1988).  Examples are found in S. aureus and also identified in Agr-like gene 
system (AgrF or Fsr) in E. faecalis (Qin et al., 2000).  These bacteria still possess protein 
histidine kinase (designated as AgrC in S. aureus (Lina et al., 1998) and FsrC in E 
.faecalis (Qin et al., 2000) but use different peptide export proteins instead of the ABC 
proteins. Additionally, AgrA (Koenig et al., 2004) is the response regulator and AgrD 
(McDowell et al., 2001) is the protein responsible for the AIP production.  AgrB (Zhang 
et al., 2002; Qiu et al., 2005) is the protein responsible for the modification of the peptide 
produced by AgrD (Zhang et al., 2004) and secretion of the modified peptide to the 
medium (Figure 4). 
These two systems have gained extra attention since S. aureus and S. epidermidis 
are the main causes of nosocomial infections. It is known that the locus agr is a global 
regulatory gene and hence responsible for a number of virulence factors (Ji et al., 1995). 
In S. aureus the strains are categorized into four agr subgroups. The expression of each 
of these agr genes can inhibit other pathways (Jensen et al., 2008). 
8 
 
 
Figure 4. Structural differences in AgrCs of Staphylococcus aureus (Jensen et 
al., 2008) (Permission granted for reproduction). 
 
Based on the pathways described, it is feasible to propose that the inhibition of 
key points in the biochemical pathway of quorum sensing could elicit a shutdown of the 
system, provoking a desirable therapeutic effect. Select AIP targets may include: i.) 
antagonism of AIP receptor; ii.) histidine protein kinase inhibitors; iii.) inhibition of 
phosphoryl transferases from the His residue to the Asp residue of the response regulator; 
iv.) inhibition of the enzymes responsible for the AIP synthesis and/or post-translational 
modification and; v.) inhibition of efflux transporters responsible for AIP effusion across 
membrane. 
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1.3 Histidine Protein Kinase Inhibitors  
 Patients with cystic fibrosis are likely to suffer from pulmonary infections. A 
common pathogen involved in such infections is Pseudomonas aeruginosa 
(Roychoudhury et al., 1993) which synthesizes the ex-polysaccaride coat alginate thus 
rendering the access of bactericidal drugs to the correspondent site of action a difficult 
task. The genes involved in alginate production are part of a two component system 
regulated by AlgR2/AlgR1.  Histidine kinase AlgR2 is inhibited by compounds 11 and 12 
while inhibitor 13 was reported to interfere with the DNA binding activity responsible for 
the response regulator AlgR1. Inhibitors 13 and 14 also act on a broader spectrum of 
histidine kinases such as CheA, NRII, KinA and VirA (Figure 5). 
 
Figure 5. Histidine protein kinase inhibitors. 
A zerumbone analog 15, Figure 6,  (Yamamoto et al., 2001) inhibited the histidine 
kinase of YycG on Bacillus subtilis (Kitayama et al., 2004).  Additional zerumbone 
analogs were synthesized (e.g., tryptophan analog 16) and found to be equipotent with 15 
(Kitayama et al., 2007).  Several analogs also exhibited activity against methicillin-
resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE).    
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Figure 6. Zerumbone histidine kinase inhibitors.  
 
1.4 AIP Antagonists 
In 1995, it was demonstrated that the virulence factors in S.aureus were controlled 
by a cell density system that made use of an octapeptide produced by the bacterium itself. 
The study also revealed that this octapeptide activated the expression of the agr locus; the 
octapeptide sequence was determined to be YSTCDFIM (Ji et al., 1995). The peptide was 
purified, characterized and synthesized but had no detectable activity.  Evaluation of the 
mass spectrometry data suggested that this synthetic peptide was dimeric and its mass 
included a neutral loss of water.  When interpreted as a whole, this led the authors to 
suggest that the cysteine in the synthetic peptide was oxidized to a disulfide and the 
natural isolated pheromone contained a cyclic thioesther introduced post-translationally. 
The hypothesis was confirmed by treatment of the native peptides with iodoacetic acid 
and hydroxylamine. Iodoacetic acid failed to react with the peptide (as evidenced by no 
free SH groups), while hydroxylamine reacted with the putative thioester, yielding a 
product that lacked biological activity (Ji et al., 1997).  
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  Additional insights were acquired through structure-activity relationship studies 
with a series of analogs synthesized to determine key residues that are involved in 
agonistic or antagonistic activity (Table 1). Conclusions were drawn from these studies 
that demonstrated the sulfur atom, when oxidized, abolishes biological activity. Also 
when the methionine was replaced with norleucine, serine, glutamic acid, lysine or 
proline, no activity was observed (McDowell et al., 2001). 
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Comp. R1 R2 R3 R4 R5 R6 IC50  ED50 
AIP-1 H-Tyr-Ser-Thr CH2CH2SCH3 Asp Phe Ile S - 19 nM 
 
H-Tyr-Ser-Thr CH2CH2SOCH3 Asp Phe Ile S - - 
 
CH3CO CH2CH2SCH3 Asp Phe Ile S 8 µM - 
AIP-II Gly-Val-Asn-Ala CH2(C6H5) Ser Ser Leu S 2 nM - 
 
CH3CO CH2(C6H5) Ser Ser Leu S 4 µΜ - 
 
H-Tyr-Ser-Thr CH2CH2SCH3 Asp Phe Ile NH - 24 µΜ 
 
H-Ala-Ser-Thr CH2CH2SCH3 Asp Phe Ile S - 161 nM 
 
H-Tyr-Ala-Thr CH2CH2SCH3 Asp Phe Ile S - 9 nM 
 
H-Tyr-Ser-Ala CH2CH2SCH3 Asp Phe Ile S - 248 nM 
 
H-Tyr-Ser-Thr CH2CH2SCH3 Ala Phe Ile S 33 nM - 
 
H-Tyr-Ser-Thr CH2CH2SCH3 Asp Ala Ile S - 9 µΜ 
 
H-Tyr-Ser-Thr CH2CH2SCH3 Asp Phe Ala S - 11 µΜ 
 
H-Tyr-Ser-Thr CH3 Asp Phe Ile S - 9.5 µΜ 
 
Table 1.   Structures and activities of diverse AIPs.  
 
The most compelling changes were achieved when alanine was introduced in the 
place of aspartic acid on the cyclic structure, which changed the nature of the peptide 
from an activator, with ED50 of 19 nM, to an inhibitor of toxic shock syndrome toxin 
(TTST-1) and enterotoxin C-3, with an IC50 of 33 nM.  D-Amino acids were also part of 
the study and analogs of AIP-1 replacing the L-amino acid residue for the D-isomer were 
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tested.  In the case of activation, the activity was reduced for most of the analogs with the 
exception of D-Phe and D-Met. 
An SAR study performed with AIPs revealed that for S. aureus, a common 
template was able to antagonize AgrC: TrAIP-II (Mayville et al., 1999).  The SAR study 
revealed important details about the interaction between the peptides produced by AgrD 
and the receptor AgrC such as: (i) the amino acid sequence and the stereochemistry of the 
AIP are critical for the interaction between the peptide and its receptor; (ii) inhibition of 
agr expression is undermined if either the amino acid sequence or stereochemistry is 
altered, but not when the changes concern the chemical reactivity of the cyclic linkage. 
The synthesis of the peptides used in the SAR study was performed using solid-phase 
protocols. 
 
  
 
 
 
 
 
Figure 7. Synthesis of S. aureus AIPs (Mayville et al., 1999) 
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 The study also proposed that AIPs of the same S. aureus class bind differently 
from AIPs of different S. aureus types. On an intraclass association, side chain 
interactions would increase the specificity leading to an adjustment that would position 
the thiol ester linkage of the peptide next to a nucleophilic group embedded on AgrC. 
Therefore a covalent bond between AgrC and the the AIP would be formed, imparting  
conformational changes on the receptor resulting in the histidine kinase to suffer trans-
phosphorylation through dimerization (Cisar et al., 2009). The aforementioned events 
would lead to the activation scenario and therefore to signal-transduction and expression 
of agr.  Regarding the interclass receptor-ligand scenario, there would not be a 
nucleophilic attack due to the non-aligment provided by the absent side-chain 
interactions. Therefore a non-covalent binding interaction would take place and no 
signal-transduction would be possible leading to the antagonistic thread (Figure 8).  
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Figure 8. Proposed model for agonism and antagonism of AgrC (Mayville et al., 
1999). (Figure reproduced with permission). 
 
It was hypothesized that the peptide side chain (sometimes referred as the tail) 
bound to the thiolactone has a fundamental role for the activation of the AgrC receptor-
histidine kinase, as well as for defining the agonistic/antagonistic nature of the AIP.  With 
this in mind, a second SAR study was conducted involving chimeric receptors and 
diverse AIPs (wild and synthetic) from a variety of Staphylococcus species. The test of 
the chimeric receptors against a number of AIP analogs localized the primary ligand 
recognition site to the receptor distal subdomain and revealed that the AIPs bind 
primarily to a putative hydrophobic pocket in the receptor (Figure 9). This interaction is 
driven in part by a highly hydrophobic moiety on the AIPs which proved to be essential 
for self- activation as well as for cross-inhibition (Wright et al., 2004).   
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Figure 9.  Strategy used to generate chimeric AgrC and alignment of wild 
AIPs from different Staphiloccocci showing the highly conserved amino acids 
9 and 8 as well as the cysteine residue (Wright et al., 2004). (Figure 
reproduced with permission). 
 
The study determined several intrinsic aspects of the AIP-AgrC interaction: i.) the 
distal region of the AgrC domain contains the primary elements involved for activation; 
ii.) the specificity for the activation in the AIP can be accounted to D5 and Y5 (Figure 9) 
on AIP-I and AIP-IV, respectively, in the macrocycle ring adjoining the conserved 
cysteine; iii.) the proximal domain of the receptor confers a secondary role in ligand 
cross-reactivity presenting the ability to react to noncognate AIPs; iv.) a massive 
hydrophobic residue, conserved on all Staphylococcus AIPs seems to be a key component 
for AgrC-AIP binding.  
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The ligand-binding event of AgrC-AIP is expected to generate conformational 
changes in the AIP and/or the AgrC receptor for activation. It is also important to note 
that the chimeric receptors can be of critical importance in the study of interactions 
between ligand and receptor (Figure 10). 
 
Figure 10: activation and inhibition of AgrC. The binding is driven by the 
hydrophobic patch (two circles) into the hydrophobic binding pocket (shaded in 
yellow). (Wright et al., 2004).  (Figure reproduced with permission) 
 
An interesting SAR study was recently reported, in which 10 analogs of trAIP-II 
(17) were synthesized (George et al., 2008).   Since compounds lacking the side chain 
would present an inhibitory effect, they were tested against AgrC-II to investigate the 
cognate effects and against AgrC-I for the non-cognate effects. The following 
conclusions were made based on the study: (i) regarding cognate and non-cognate 
inhibitory effect, both groups have similar tendencies; (ii) from the compounds that have 
measurable activities it was observed that the antagonism for the non-cognate receptor 
(AgrC-I) was stronger than of the cognate-receptor (AgrC-II); (iii) a main pharmacophore 
group for agr antagonism in trAIP-II was improved.  One half of the molecule including 
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cysteine and two terminal hydrophobic residues are critical for activity. The remainder of 
the molecule seems to be non-essential as shown in Figure 11. 
  
 
 
 
 
Figure 11.  Proposed pharmacophore model for trAIP-II. 
 
Other AgrC antagonists were discovered in a unique SAR study involving AIP-
1(18) and AIP-2 (19).  Some issues were considered in designing the features for AgrC 
antagonists: (i) two amino acids in the macrocycle are essential for the interactions of 
AIP-1 and AIP-2 with their respective cognate receptors, Phe6Ile7 (in AIP-1) and 
Leu8Phe9 (in AIP-2); (ii) the substitution of the aminoacid vicinal to the highly conserved 
cysteine (Asp5 for AIP-1 and Ser6 for AIP-2) for an Ala residue resulted in a powerful 
AgrC competitive antagonist (Mayville et al. 1999; McDowell et al., 2001; Lyon et al., 
2002).  Indeed, (Ala5)AIP-1 (Figure 12) is a potent inhibitor on all S. aureus AgrCs with 
IC50 values ranging between 0.3 and 21 nM; (iii) analogs lacking the exocyclic tail are 
weak antagonists although the exocyclic tail seems to have an impact on the macrocyclic 
“address” affinity.  1H-NMR studies were performed on the (Asp5) AIP-1 analog.  The 
hydroxy belonging to Ser2 and Thr3 revealed a doublet at δ 4.95 and a triplet at δ 5.24 
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while the hydroxyls for AIP-1 revealed two broad singlets. This implied that the hydroxy 
groups in (Asp5)AIP-1 are solvent shielded with a very slow rate of exchange. Therefore 
it was proposed that a substitution of Asp5 for an Ala residue would provoke minor 
changes in the macrocyclic conformation but would induce critical adjustments in the 
exocyclic tail culminating in an affinity increase (Chan et al., 2004).   
 
Figure 12.  AIP-1 and (Ala5)AIP-1. 
 
Based on (Ala5)AIP-1 an additional set of analogs were synthesized and 
evaluated.   The replacement of Asp5 by Ala did not affect activity. The replacement of 
Tyr1 by biphenyl moieties had an impact on the affinity for AgrC-1, but not for AgrC-2.  
Biostability is always an issue when one considers drug design strategies 
(Grabley, 1999). With this in mind, N-substituted glycines oligomers, or peptoids, have 
been shown to be valuable peptide mimetics due to their high stability and relative ease 
of synthesis (Patch, 2004). Additionally, many biologic phenomena have been reported to 
be probed by peptoids (Hara et al., 2006; Xiao et al., 2007).  
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Peptomers (peptide-peptoid hybrids) (Østergaard & Holm, 1997) were proposed 
as feasible mimetics for AIP-1, following the logic of previous SAR works (Fowler et al., 
2008). A series of peptomers were tested and it was discovered that one of them was able 
to stimulate bio-film formation, presenting an agonistic role in S. aureus quorum sensing 
(Figure 13). 
 
 
 
 
Figure 13.   Peptomer with biofilm stimulatory activity on S. aureus. 
 
Recently antibodies were used as AIP antagonists (Park et al., 2007). Initial focus 
centered on the AIP-4 QS system and its cognate strains RN4850 and NRS168 (Lyon et 
al., 2000). The hapten AP-4 (21) was designed with a major concern in mind, 
replacement of the native thiolactone for a lactone-containing hapten in order to improve 
aminolytic stability (Shigenaga & Janda 2006). This strategy prevented any structural 
change during the immunization process therefore averting the production of compounds 
generated due to degradation haptens (Kaufmann et al., 2005), as well as a possible intra 
molecular thiol exchange. The antibody was obtained through the immunization of mice 
after synthetic AP4-hapten 5 (22) was conjugated with carrier proteins keyhole 
hemocyanin (KHL) and bovine serum albumin (BSA) (Figure 14). 
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Figure 14.  Structures of AIP-4 and AIP-4 hapten-5.  
 
Twenty monoclonal antibodies (mAbs) were prepared and one of them, AP-
24H11, had a strong binding affinity for AIP-4 (Kd AIP-4 = 90 nM) when compared to 
other AIPs (Kd AIP-1 = 5 mM, Kd AIP-2 = 25 mM, Kd AIP-3 = 25 mM). AP-24H11 showed an 
impressive aptitude to discriminate AIP-1 from AIP-4 (the difference between them one 
aminoacid, an aspartic acid residue for AIP-1 on position 5 instead of a tyrosine residue 
for AIP-4). This high level of recognition led the authors to a further investigation of 
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mAb AP4-24H11 which reduced the expression of α-hemolysin and increased the 
production of protein A in the strains of group IV, RN4850 and NRS168.  Such results 
are consistent with the hypothesis that mAb AP4-24H11 is able to modulate the quorum 
sensing in S. aureus of group IV. The pathogenicity of S. aureus in an in vivo abscess 
formation mouse model could also be suppressed showing that mAbs are feasible tools to 
suppress QS associated with S. aureus virulence. 
 
1.5 AHL Quorum Sensing Pathway 
 A large number of Gram-positive bacteria uses AHL (acyl homoserine lactone) as 
signaling molecules in their quorum sensing system. The AHLs consist of a fatty acyl 
chain that is linked to a lactone (generated from an homoserine) through an amide bond. 
The AHLs possess a significant chemical diversity among bacteria. Even the same 
bacteria can synthesize different types of AHLs. The structural divergences are focused 
on the size and composition of their acyl chain.    
 Usually the length of the chains has been reported to range between 4 to 16 
carbons. The chains may have double bonds which can vary from increments of two 
carbon units as in C4, C6 and C8. The third carbon in the chain can be a carbonyl or 
simply bear a hydroxy, or in the simplest case, be fully reduced to an alkyl carbon. The 
diversity on the third position occurs merely in the biosynthetic process (Figure 15). In 
the case of Pseudomonas aeruginosa for example FabG is responsible for the reduction 
of the carbonyl of C-3 in acetoacetyl-ACP to d-3-hydroxybutyryl-ACP (Hoang et al., 
2002). 
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Figure 15.  Biosynthesis of homoserine lactones in Pseudomonas aeruginosa. 
 The quorum sensing in Gram-negative is regulated by a large number of 
regulatory proteins.  Among them the Lux-R proteins are the most studied. Most of the 
Lux-R family of proteins are transcriptional activators responsive to AHL, although the 
repressors also exist in nature (Swift  et al., 1997). Table 2 illustrates the AHL diversity, 
in addition to the bacteria, signal, regulators, and the expressed phenotype.   
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Entry Bacterium AHL structure Designation LuxI/R QS phenotype Target or 
Effect on 
host 
1 Aeromonas 
hydrophila 
 
 
(Swift et al., 1997) 
BHL, C4 Ahy/AhyR Exoprotease 
production 
 
2 Aeromonas 
salmonicida 
 
 
(Swift et al., 1997) 
BHL, C4 AsaI/AsaR Extracellular 
prorease 
 
3 Agrobacterium 
tumefaciens 
 
 
(Zhang et al., 2002) 
OOHL 
 3-oxo-C8 
TraI/TraR conjugal transfer 
of the Ti plasmid 
 
Crown gall 
tumor; large 
growths on 
plant host 
4 Burkholderia 
cenocepacia 
 
(Lewenza et al., 1999) 
 
(Sokol et al., 2003) 
HHL, C6 
 
 
 
 
 
OHL, C8 
CepI/CepR Biofilm, 
swarming 
motility, 
virulence 
Opportunistic 
human 
pathogen; 
common 
infection in 
CF patients; 
may cause 
disease in 
plants 
5 Burkholderia 
pseudomallei 
 
(Kiratisin and Sanmee 2008) 
 
(Ulrich et al., 2004) 
OHL, C8 
 
 
 
 
3-hydroxy-C8 
PmlI1/Pml
R1 
 
 
 
PmlI2/Bpm
R2 
Virulence, 
exoprotease 
Melioidosis, 
affects lungs, 
heart, brain, 
liver, kidneys, 
commonly 
found in 
Southeast Asia 
6 Chromobacterium 
violaceum 
 
(McClean et al., 1997) 
HHL, C6 
 
CviI/CviR Exoenzymes, 
cyanide, pigment 
Rare human 
pathogen, can 
cause skin 
lesions and 
sepsis 
7 Erwinia 
caratovora 
 
 
(Welch et al., 2000;  
Burr et al., 2006) 
OHHL, 
3-oxo-C6 
ExpI/ExpR 
CarI/CarR 
Carbapenem, 
exoenzymes, 
virulence 
Plant 
pathogen; 
Common 
cause of decay 
in stored fruits 
and vegetables 
8 Erwinia 
chrysanthemi 
 
(Castang et al., 2006) 
OHHL, 
3-oxo-C6 
ExpI/ExpR 
 
Pectate lyases 
 
 
9 Erwinia stewartii 
 
(von Bodman et al., 1998) 
OHHL, 
3-oxo-C6 
EsaI/EsaR 
 
Exopoly-
saccharide, 
virulence 
factors 
 
 
10 Photobacterium 
fischeri  
(Vibrio fischeri) 
 
 
(Schaefer et al., 1996) 
 
(Gilson et al., 1995;  
Lupp & Ruby 2004) 
OHHL, 
3-oxo-C6 
 
 
 
OHL, C8 
 
LuxI/LuxR 
 
 
 
 
AinS/AinR 
bioluminescence 
symbiosis 
 
 
 
bioluminescence 
symbiosis 
Luminescent 
bacterium 
found in light 
organs of 
monocentrid 
fish and 
sepolid squid 
11 Pseudomonas 
aureofaciens 
 
(Zhang & Pierson 2001) 
HHL, C6 
 
PhzI/PhzR Phenazine 
antibiotics 
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12 Pseudomonas 
aeruginosa 
 
 
(Smith et al., 2002) 
 
(Smith & Iglewski, 2003) 
OdDHL,  
3-oxo-C12 
 
 
 
BHL, C4 
LasI/LasR 
QscR 
 
 
 
RhlI/RhlR 
 
alkaline protease, 
elastase, cyanide 
(HCN) 
production, 
hemolysin, 
exotoxin A, 
neuraminidase, 
pyocyanin and 
rhamnolipid 
production 
 
Oportunistic 
pathogen; one 
of the major 
causes of 
hospital 
acquired 
infections 
(urinary tract, 
burn, external 
ear) 
13 Pseudomonas 
putida 
 
 
(Steidle et al., 2002) 
OdDHL,  
3-oxo-C12 
 
 
ODHL,  
3-oxo-C10 
 
 
PpuI/PpuR Biofilms Saprophytic 
soil bacterium; 
bioremediatio
n of 
naphthalene 
contaminated 
soils 
14 Rhizobium 
leguminosarum 
 
(Schripsema et al., 1996; 
Yajima et al., 2008) 
 
 
(Gray et al., 1996) 
 
3-Hydroxy-7-
cis-C14 
 
 
 
 
HHL, C6 
 
CinI/CinR 
RhiI/RhiR 
RaiI/RaiR 
TraR 
BisR 
Root nodulation, 
Symbiosis, 
plasmid transfer, 
Growth inhibition 
Symbiotic 
nitrogen fixing 
bacterium to 
legumes (e.g. 
peas) 
15 Rhodobacter 
sphaeroides 
 
(Puskas et al., 1997) 
7-cis-C14-HSL 
 
CerI/CerR 
 
Dispersal from 
bacterial 
aggregates 
 
 
16 Serratia 
liquefaciens 
 
 
(Eberl et al., 1996) 
BHL, C4 
 
 
 
HHL, C6 
SwrI/SwrR 
 
Extracellular 
protease, 
swarming 
 
 
17 Sinorhizobium 
meliloti 
 
 
 
 
 
 
 
 
 
 
 
 
(Marketon et al., 2002) 
DDHL, C12 
 
 
 
 
 
3-oxo-9-cis-C16 
 
 
9-cis-C16:1 
SinI/SinR 
ExpR 
TraR 
 
 
 
 
 
 
Nodulation and 
symbiosis 
Symbiotic 
nitrogen fixing 
bacterium to 
legumes (e.g. 
alfafa) 
18 Vibrio 
anguillarum 
 
 
(Milton et al., 1997) 
OdDHL,  
3-oxo-C12 
 
VanI/VanR 
 
 terminal 
hemorrhagic 
septicemia 
known 
as vibriosis in 
fish 
 
19 Vibrio harveyi 
 
(Cao & Meighen, 1989) 
3-hydroxy-C4-
HSL 
LuxLM/ 
LuxN 
Bioluminescence  
20 Yersinia pseudo-
tuberculosis 
 
OOHL 
 3-oxo-C8 
 
 
 
YpsR/YpsI 
 
 
 
 
Regulation of 
clumping and 
motility 
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(Atkinson et al., 1999) 
HHL, C6 YtbR/YtbI 
21 Yersinia pestis 
 
 
 
(Kirwan et al., 2006) 
ODHL,  
3-oxo-C10 
 
OHHL, 
3-oxo-C6 
YspI/YspR 
 
 
Ype/YpeR 
 
Regulation of 
clumping and 
motility 
 
Table 2.  AHLs, bacteria, and receptors associated with their quorum sensing.  
Phenotype regulated by the QS and effect on the host. 
  
 It is interesting to note the immense variety of bacteria that use quorum sensing 
involving AHLs.   The historically relevant species, Yersinia pestis, was responsible for a 
number of epidemic episodes including The Plague of Justinian in 542 A.D. and the 
Black Death, which occurred from 1347 to 1353 A.D. and wiped out at least one third of 
the European population.  More important is to realize that many of these bacteria 
produce the exact same chemical signal, but use them for different functions. For 
example OHHL is produced by Vibrio fischeri and by Yersinia pestis; two completely 
different bacteria regarding pathogenicity, yet they are able to provide distinct phenotypic 
response when in contact with a certain concentration of OHHL.  
The LuxR type proteins, which are the receptors of the acyl-HSL, can be 
subdivided in two domains. The first one contains the binding site which is located near 
the N-terminal of the protein. Mutations on that site proved to extinguish the binding of 
3-oxo-C6-HSL to LuxR (Hanzelka, 1995). Further studies proved that it is also possible 
to block the effects of cognate autoinducers, generating per se an antagonic response 
(Schaefer et al., 1996). The second domain, containing the C-terminus, has a helix-turn-
helix (HTH) motif, which is required for DNA binding. When the binding between the 
acyl-HSL and the N-terminal domain occurs it leads to a series of conformational 
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changes that culminate in multimerization of the complex LuxR type protein-acyl-HSL 
and further DNA binding.  
A greater insight of the binding mechanism was acquired with the crystallization of 
TraR (a close homolog of LuxR from Agrobacterium tumefaciens) with its cognate ligand 
(3-oxo-C8-HSL) and a oligonucleotide, as depicted in Figure 16 (Zhang et al., 2002). 
 
  
Figure 16. Binding site of 3-oxo-C-HSL after dimerization. (Figure reproduced 
with permission). 
 
 In the case of TrA, after its cognate ligand binds to its site in the N-terminal 
region, it forms a dimer, with each monomer being composed of two folded domains 
attached by a flexible linker region. This domain forms an α-β-α sandwich that 
coordinates ligand interactions through the central β sheet. The central β-sheet has five 
anti-parallel strands and is curved, with the 3-oxo-C8-HSL bound to its concave surface. 
The pheromone is fully surrounded by the protein and has no significant contact with 
solvent. Hydrophobic and aromatic residues comprise most of the 3-oxo-C8-HSL binding 
pocket. The acyl chain runs parallel to a β-sheet surface and is surrounded by lipophilic 
side chains in the protein. 
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The fact that the ligand is completely surrounded by the protein draws a distinction 
from the typical concept of ligand-receptor in which the receptors hold the ligand-binding 
site exposed. That indicates that the actual “receptor” for 3-oxo-C-HSL in  
Agrobacterium tumefaciens is the “nascent” unfolded form of TraR (Zhu & Winans, 
2001). 
After the dimer is formed and the “nascent conformation is changed”, the complex 
binds to DNA through the HTH motif. Transcriptional activation of the associated 
promoter follows the binding of the lux type box. 
 
1.6 Inhibitors of AHL Synthesis  
Biofilms, in particular, have received special attention since their formation 
protects bacteria from treatment with antibiotics as well as from the host immune system. 
The treatment of bacterial infections where a biofilm is present represents a challenge in 
therapeutic settings. Concerning this matter, autoinducer analogs were synthesized and 
tested against Pseudomonas aeruginosa. Several proved to be efficient in reducing both 
virulence factors and biofilm formation (Figure 17) demonstrating that small template 
molecules based on quorum sensing can provide a new insight to the generation of 
antibacterial agents (Smith et al., 2003). 
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Figure 17. Inhibition of biofilm formation by autoinducers analogs on 
Pseudomonas aeruginosa. (Figure reproduced with permission. 
 
The design and synthesis of artificial AHLs proved to be strong inhibitors of the 
production of virulence factors, which are necessary for pathogenesis (Geske et al., 
2007). This also corroborates the fact that small molecules involved in quorum sensing 
can serve as templates for the development of new antibacterial agents.  
Therefore, the identification of synthetic small molecules that can play either an 
antagonist or agonist role in the quorum sensing process represents a valid pursuit in the 
design and development of new antibiotics. 
The next section will describe methods for the construction of oxetane rings, 
based on the recent identification of a new QS molecule, bradyoxetin (23; Figure 18).    
 
Figure 18. Structure of bradyoxetin. 
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CHAPTER 2: OXETANE RING SYNTHESIS 
2.1 Introduction to oxetanes 
 Oxetanes are defined as four member ring cyclic ethers. This functional group is 
present in a number of pharmacologically relevant and complex natural products 
including the antitumor agent paclitaxel (24), the antiviral agent oxetanocin (25), and the 
endogenous antiplatelet agent thromboxane A2 (26).    
 
Figure 19. Pharmacologically relevant molecules containing an oxetane ring. 
 
 A number of other “less celebrated” natural products containing the oxetane ring 
have been isolated from nature (Figure 20) including mitrephorone A (27; Li et al., 
2005), (+)-(Z)-laureatin (28; Irie et al., 1968; Irie et al., 1970; Kurosawa et al., 1973), 
dictyoxetane (29),   merrilactone (30) and one of the simplest oxetanes, oxetin (31). 
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Figure 20. Additional natural products containing an oxetane ring. 
 
2.1 Synthesis of oxetanes: Intramolecular cyclization reactions 
The most common way to synthesize an oxetane ring is through the use of an 
intramolecular 4-exo-tet-displacement reaction. This strategy has been used for the 
incorporation of constrained oxetane rings as in the synthesis of the the natural product 
paclitaxel and into carbohydrate backbones (Christensen, 2003). Studies have shown that 
the 4-exo-pathway most often is the preferable way to proceed with the cyclization 
instead of the chemically permitted 5-exo and 3-exo cyclizations. The leaving groups are 
commonly mesyl (Brennan et al., 2004), tosyl (Holton et al., 2002; Isaacs et al., 2002) 
and halogens (Uttaro et al., 2005).  Scheme 1 depicts the 4-exo-tet transformation in the 
synthesis of the oxetane ring of paclitaxel analogs, using precursors 32 or 33 for the 
construction of 34.   
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Scheme 1. Formation of oxetane rings via 4-exo-tet displacement reactions.  
 
 In total synthesis of isomeric laureantins, a 4-exo-tet-displacement was used to 
install the oxetane ring (Scheme 2). The beauty with this strategy lied in the formation of 
a key substrate (35) that would serve a double task, namely, for the installment of a furan 
ring in intermediate (36), ultimately used for (+)-3-(Z)-isolaureatin production, and for 
oxetane ring formation (compound 37), for  (+)-3-(Z)-laureatin synthesis (Kim et al., 
2007). 
 
 
 
 
 
Scheme 2.  Synthesis of laureantin and isolaureatin precursors utilizing 4-
exo-tet-displacement reactions. 
 
Oxetane rings were also produced in studies involving the synthesis of 
gymnomitrane terpenoids (Scheme 3).  Treatment of tosylated 38 with bulky non-
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nucleophilic bases led to the formation of oxetane 39 and ring-expanded product 40, 
formed as a result of a Grob fragmentation reaction  (Toyota et al., 2000). 
 
Scheme 3.  Oxetane ring synthesis vs. Grob fragmentation. 
 
In an attempt to synthesize oxetin (31) analogs (Jenkinson et al., 2004), an 
approach based on the use of chiral pool D-xylose was examined (Scheme 4). The 
oxetane ring was constructed through a ring contraction of α-triflate-γ-lactone (41) with 
K2CO3 in methanol at low temperature, affording bicyclic oxetane 42. 
 
 
 
Scheme 4.  Synthesis of oxetanes through ring contraction of α-triflate-γ-lactones. 
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The bicyclic oxetane 42 was submitted to three separate reaction types to reveal 
its utility as a useful building block (Scheme 5).  Deprotection of the acetonide afforded 
diol 43, while treatment with triethylsilane and trifluoroacetic acid led to the selective 
formation of secondary alcohol 44 (DeNinno et al., 1995).  Finally, a bromination 
reaction using Hanessian-Hullar conditions with N-bromosuccinamide afforded 45 
(Hullar & Siskin 2002). 
 
 
 
Scheme 5.   Generation of oxetane building blocks. 
 
Oxetane 44 was further submitted to a series of protection and SN2 displacement 
reactions that ultimately led to the production of azido oxetanes 45 and 46, suitable latent 
amine precursors for future drug discovery efforts (Figure 21)  (Jenkinson et al., 2004).  
 
 
Figure 21.  Azido oxetanes as latent amine precursors. 
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 The formation of oxetane 48 from a polycyclic system 47 revealed a very 
uncommon displacement reaction on a tertiary center (Khan et al., 2005). The conjugate 
addition of an alkoxide to an alkynoate 49 was also used for the formation of oxetane 50 
(Scheme 6) (Wendling & Miesch 2001). 
 
 
 
 
 
Scheme 6.  Uncommon oxetane ring synthesis reactions.   
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2.2 Synthesis of oxetanes: Electrophilic cyclization reactions 
Oxetanes can also be formed through electrophilic cyclization reactions of 
unsaturated alcohols.  One of the first examples reported invoked the addition of NBS to 
a δ-hydroxy vinylsilane 51 derived from adamantanone (Scheme 6). The product was a 
curious adamantane spirooxetane 52 (Ehlinger & Magnus 1980).  
 
 
 
Scheme 7.  Synthesis of oxetanes through electrophilic cyclization reactions. 
 
Similar transformations were performed with vinylsilanes to investigate 
mechanistic issues in the cyclization reaction.  For example, vinylsilane homoallylic 
alcohols 53 and 54 furnished spirooxetanes 55 and 56, respectively, when treated with 
bis(syn-collidine) bromine(I) hexafluoroantimonite (Rofoo et al., 2001). When the 
hydroxy group occupied a secondary carbon or, conversely, the proton β to the hydroxy 
group was substituted with a methyl group, diastereoselectivity was not preserved.  
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Scheme 8.  Synthesis of oxetanes using bis-collidine complexes. 
 
The electrophilic cyclization reaction of homoallylic alcohols using NBS has also 
provided a powerful method for generating molecules suitable for X-ray crystal 
diffraction studies and absolute configuration determination (Scheme 8).  For example, 
treatment of 57 with NBS afforded the bromo-oxetane 58 (Manabe et al., 1985), while 
reaction of 59 with NBS yielded the dibromo-oxetane 60 (Paquette et al. ,1999).   
 
 
 
 
Scheme 9.  Reaction of homoallylic alcohols with NBS. 
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These reaction types are not limited to the use of NBS.  In fact, the reactive 
reagent N-iodosuccinimide (NIS) was also employed in the synthesis of neoclerodane 
diterpenoids containing an oxetane moiety 62 from its respective homoallylic alcohol 61 
(Scheme 9) (de la Torre et al., 2000).  
 
 
 
 
 
Scheme 10.  NIS mediated oxetane synthesis. 
Endo-Norborneols containing tertiary hydroxy groups (e.g., 63) have been 
reported to react with phenylsulfonyl chloride and n-BuLi providing oxetanes (e.g., 64) 
and hence generating an intricate oxatricyclo[3.2.1.03,6]octane (Scheme 9) (Brown & 
Fallis 1985).   
 
Scheme 11. Synthesis of a tricyclic oxetane from endo-Norborneols. 
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Further studies involving norbornenes were conducted with the aim of 
investigating the regio- and stereoselectivity of electrophilic addition reactions using 
phenylselenyl chloride and phenylsulphonyl chloride (Scheme 10). The formation of the 
oxetane occurred with substrates bearing an endo-hydroxy group (65 to 66); as 
anticipated, exo-hydroxy substrates 67 failed to produce the oxetane product, but rather, 
formed the standard olefin addition product 68.  (Arjona et al.,1987; Arjona et al., 1989; 
Arjona et al., 1992).  
 
 
 
 
 
Scheme 12.  Stereochemical requirements for oxetane ring synthesis. 
  
 Electrophilic cyclization reactions were employed utilizing homoallylic alcohols 
(69-71) and [I(collidine)2+]ClO4- complexes, generating three to seven member ring 
iodoethers, including oxetanes (72-74), which were produced in satisfactory yields 
(Scheme 11) (Evans, 1988). 
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Scheme 13. Synthesis of iodo-oxetanes with [I(collidine)2+]ClO4-. 
 
Electrophile-mediated cyclization reactions of homoallylic alcohols possessing an 
ester group were also scrutinized. The reaction was prone to form oxetanes in addition to 
tetrahydrofurans in the presence of iodine and acetonitrile.  When silver triflate was 
added the process suffered a significant acceleration. Generally the cyclizations have 
presented good stereocontrol for both oxetanes and tetrahydrofurans (Galatsis et al. 1994; 
Galatsis & Parks 1994; Galatsis et al., 1997). Replacement of the ester with the Evans 
chiral auxiliary (75) afforded oxetane products (76-77) with a good diastereoselectivity 
(Scheme 12)  
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Scheme 14. Evans chiral auxiliary-directed oxetane synthesis. 
 
An interesting report concerning the synthesis of a [2.2.0] fused ketal 81 was 
disclosed (Wang et al., 1999), prepared from the initial Mitsunobu inversion reaction of 
78 in the formation of β-lactone 79 (Scheme 13).  This product was carried through 
several reactions, ultimately leading to the production of compound 80, subsequently 
transformed into ketal 81 using an electrophilic cyclization reaction (Dollinger et al., 
1999).  
 
Scheme 15. Synthesis of a [2.2.0] oxetane (ketal). 
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 Other examples involving electrophylic cyclizations for the synthesis of oxetanes 
include the use of NIS in DCM (Barks et al., 1994), I(coll)2ClO4 in DCM for the 
production of oxetane-dimethanols as oxetanocins analogs (Jung & Nichols 1996), and 
the use of  silver(I)oxide (Alonso,  2000) and mercuric triflate (Imagawa,  1998) as 
electrophilic reagents. 
 
2.3 Synthesis of oxetanes: Cationic cyclization reactions 
Cationic cyclization reactions have been used to promote oxetane formation 
(Craig et al., 1999). Thiopyridyl acetals containing a silyl enol ether (82-83) proceed 
through intramolecular reactions promoted by silver (I) to provide cis-[3.2.0] substituted 
oxetanes (84-85) bearing an exo-acyl group (Scheme 14).  
 
 
 
 
 
Scheme 16.  Cationic cyclization reactions of thiopyridyl acetals. 
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The cyclization reactions were conducted with pure diastereomer substrates in 
order to gain mechanistic insight. A model to explain the cyclizations was proposed in 
which the oxetane ketone substituent is placed exo- on the bicyclic system. The silyl enol 
ether was not reactive using these cyclization conditions.  The reaction proved to be 
consistent with the existence of an intermediate carbenium ion (Figure 22). 
 
 
 
Figure 22.  Cationic intermediates in cyclization reactions. 
Similar reaction conditions were employed using carbohydrate substrates, since 
more highly oxygenated systems could have impaired the stability/lifetime of the 
anomeric cations (Scheme 15). The same authors provided a similar example where the 
generated cation is stabilized by an exocyclic thioether. 
 
 
 
Scheme 17. Carbohydrate substrates in cationic cyclization reactions. 
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2.4 Synthesis of oxetanes: Rearrangment of epoxides 
Azo-epoxides 88 can undergo photochemical fragmentation to provide oxetanes 
(e.g. 89) through a 1,2-shift of the C-O bond in the intermediate diradical (Scheme 16) 
(Abe et al., 2002). 
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Scheme 18. Photofragmentation of azo-epoxides to produce oxetanes. 
 
trans-2,3-Epoxycyclooctanol (90) reaction with DAST provided the expected 
epoxy fluoride 91 as well as a 2-fluorooxetane (92) (Scheme 17). The explanation for the 
formation of 92 is based on the classic Wagner-Meerwein shift (Lakshmipathi et al., 
2002). 
 
Scheme 19. Synthesis of oxetanes through epoxide rearrangements. 
 
Chiral hydroxyoxetanes (94) are produced as a result of an intramolecular 4-exo-
cyclization reaction when benzyl or propargyl ether tethered epoxides (93) and mixed 
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alkyllithium and/or metal alkoxide superbases like LIDAKOR are used (Scheme 18) 
(Mordini et al., 2001).  
 
Scheme 20. Synthesis of oxetanes via cyclization reactions of epoxy ethers. 
 
3,4-Epoxyalcohols can suffer isomerization under acidic or basic conditions, as 
observed in the synthesis of dictyoxetane (Proemmel et al. 2002), first isolated from the 
known brown algae Dictyota dichotoma (Pullaiah et al., 1985) (Rao et al., 1986).   The 
same observations were exploited in the final step of merrilactone synthesis (Birman & 
Danishefsky 2002; Inoue et al., 2006; He et al., 2007; Inoue et al., 2007). The literature 
refers to this rearrangement as an acid-induced homo-Payne rearrangement (Scheme 19). 
A similar acid-promoted tandem rearrangement-cyclization reaction was observed in 
epoxyalcohols containing benzyl ethers (Mosimann, 2000). 
 
 
Scheme 21. Homo-Payne rearrangement in the synthesis of merrilactone. 
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During the synthesis of phytuberin, it was found that diol 98 [generated from the 
starting material (-)-α-santonin (97)] treated with methanesulfonic acid, proceeded 
through an uncommon 4-endo-tet cyclization, generating an unexpected oxetane 99 
(Scheme 20) (Prange et al., 2003).  
Scheme 22. Formation of oxetanes through 4-endo-tet-cyclization.  
In the first total synthesis of laureatin (Sugimoto et al., 2007), the authors 
exploited a biogenetic pathway in an attempt to convert an oxocene to bicyclic skeletons 
by using a bromo-cationic cyclization reaction.  Unfortunately, undesirable cyclization 
reactions forced the group to seek an alternative route that would provide the laureatin 
skeleton.  The successful pathway exploited a 4-exo-tet cyclization reaction of the 
epoxyalcohol 100 with KOH in DMSO at 80oC affording oxetane 101 (Scheme 21).   
 
 
 
 
Scheme 23. Synthesis of laureatin precursors via epoxyalcohol rearrangements. 
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An unusual oxetane ring formation reaction was reported in attempts to prepare 
paclitaxel using model substrates; a transannular cyclization and rearrangement occurred 
when epoxide 102 (Scheme 22) was treated with KOH in DMSO, leading to the 
formation of oxetane 103 (Johnston et al. 1998).    
 
 
 
Scheme 24.Oxetane synthesis through an α-ketol ring contraction. 
 
2.5 Synthesis of oxetanes: 4-endo cyclization reactions 
 The formation of oxetanes through 4-endo-cyclizations is uncommon. The 
examples reported in the literature utilize allylic alcohols as substrates and 
bis(collidine)bromine(I) hexafluorophosphate (Homsi & Rousseau 1998). Cinnamic 
alcohols 104 or 105 produce the same trans-substituted oxetane 106, implying cationic 
intermediates (Scheme 23). 
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Scheme 25. Example of a 4-endo cyclization reaction.  
 
Studies on reaction of bicyclo[4.4.0] bridgehead alcohols 107 with NBS also 
suggests a 4-endo cyclization reaction, with the formation of dibromo-oxetane 108 
(Scheme 24) (Wempe & Grunwell 1995).  
 
 
 
 
Scheme 26. Synthesis of a dibromo-oxetane. 
.  
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CHAPTER 3:  RESULTS AND DISCUSSION 
3.1 Introduction  
 Our initial efforts are directed towards the total synthesis of the unique quorum 
sensing molecule bradyoxetin (23), in an attempt to confirm its absolute configuration 
and to explore opportunities for analog synthesis (Figure 23).  A total synthesis of the 
four possible stereoisomers and comparison with the data from the natural product would 
confirm its structure. To date, there are no reported syntheses of bradyoxetin. 
 
Figure 23. Bradyoxetin and oxetin structures. 
Our first approaches towards the synthesis of bradyoxetin were based on the first 
total synthesis of (2R,3S)-3-aminooxetane-2-carboxylic acid (31, oxetin), an amino acid 
oxetane isolated from Streptomyces sp. OM-2317 (Omura et al., 1984). Its absolute 
configuration was determined by X-ray crystallography and later confirmed by total 
synthesis (Kawahata et al., 1986).  The first reported and rather cumbersome synthesis of 
31 began with aldehyde 109, synthesized in several steps from D-glucose (Scheme 25). 
Reaction of 109 with the appropriate phosphorane using standard HWE conditions 
afforded a mixture isomeric esters, separable by silica gel chromatography. The reduction 
of the esters with DIBAL-H furnished Z- and E-allylic alcohols (110 and 111 
respectively) as shown in Scheme 25.  
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Scheme 27. Initial steps of the D-glucose pathway for oxetin synthesis. 
Independent reactions of 110 and 111 with m-CPBA afforded a mixture of four 
diastereomeric epoxides (112-115). The epoxides were separated using standard 
chromatographic techniques, and subsequently were converted to azido-oxetanes (116-
119) in three steps following a procedure previously reported (Scheme 26) (Behrens, 
1983).  
 
Scheme 28. Azido-oxetanes derived from chiral epoxides.   
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Each azido-oxetane (116-119) was converted to an oxetin isomer through a six-
step sequence that involved: i.) hydrogenation (10% Pd/C) to convert the azide to the 
amine group; ii.) protection of the amine with a CBz group; iii.) deprotection of the 
acetonide auxillary with 0.1 N H2SO4 to furnish 1,2 deprotected furanosides; iv.) 
reduction with sodium borohydride; v.) oxidation with sodium periodate and RuCl3; vi.) 
CBz group deprotection.  This yielded four pure stereoisomers, of which, the oxetane 
product derived from 116 matched with the naturally occurring product, and its structure 
was confirmed as (2R,3S)-3-aminooxetane-2-carboxylic acid (31) (Scheme 27).   
 
Scheme 29. Synthesis of oxetin and its stereoisomers. 
 
3.2   First Synthetic Approach to Bradyoxetin 
Based on the synthesis reported for oxetin, a retrosynthetic approach was 
formulated (Scheme 28) where the key features invoked the use of an appropriate 
aldehyde A in either a Wittig reaction for the generation of E-cinnamic esters, or 
conversely, a Horner-Wadsworth-Emmons (HWE) reaction for the generation of the Z-
cinnamic esters.  Standard DIBAL-H reduction of the α,β-unsaturated esters followed by 
a Sharpless epoxidation reaction of the resulting allylic alcohols would lead to chiral 
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epoxides (B).  The epoxide stereoisomers would then be converted in independent 
reactions to the mono-tosylated amine (C) for the creation of oxetanes (D).  To produce 
the symmetrical imine we envisioned using cobalt octacarbonyl catalysts to generate a 
ketone (Enquist et al., 2003) subsequent conversion to the hydroxylamine (Ulbrich et al., 
2006) and finally, to the requisite product 23 (Akazome et al., 1990).   
 
Scheme 30. First retrosynthetic approach to bradyoxetin. 
 
Our first synthetic approach began with a simple Wittig reaction between 4-
iodobenzaldehyde (123) and (carbethoxymethylene)triphenylphosphorane (124) which 
yielded the E-ester 125 as the predominant product (Scheme 29) (Couladouros & Soufli 
1995). The ester obtained from this reaction contained a minor amount of the Z-isomer 
which was not separated at this stage.  Ester 125 was reduced to the allylic alcohol 126 
with DIBAL-H (Boger et al., 1994). This product was submitted to a Sharpless 
asymmetric epoxidation yielding ((2S,3S)-3-(4-iodophenyl)oxiran-2-yl)methanol (127) 
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using titanium isopropoxide, (+) L-diisopropyltartrate and t-butylhydroperoxide (Boger et 
al., 1994).  
 
 
 
 
 
Scheme 31. Synthesis of chiral epoxide 127 from 4-iodobenzaldehyde. 
The Katsuki-Sharpless asymmetric epoxidation (Katsuki & Sharpless 1980) 
opened a new spectrum of possibilities in the context of chiral synthesis of compounds 
with relevant biological activity. It has been extensively applied to reactions of 2,3-
epoxyalcohols with a variety of nucleophiles (Hanson, 1991). It is noteworthy that the 
synthetic utility of these intermediates is highly dependent on the regioselectivity of the 
addition reaction.  The majority of epoxides are reactive towards metal azides or even 
organoazides, such as Me3SiN3.  In order to improve their reactivity, the addition of 
catalysts to the reaction are usually employed. Common catalysts include ammonium 
salts (Bonini et al., 1995; Schneider, 2000), AlCl3 (Fringuelli et al., 2001) and copper(II) 
salts (Fringuelli et al., 2003). The regioselectivity of azidolysis is very similar to that of 
other nucleophiles. To summarize, monoalkyl epoxides suffer nucleophilic attack by 
azides preferentially at the terminal methylene group where styrene-based epoxides suffer 
attack on the benzylic carbon. 
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The epoxide 127 was subsequently reacted with sodium azide in methanol in 
order to generate the required 1,3-diol 128 (Scheme 30).  Unfortunately, analysis of the 
azide addition product by 1H-NMR and 13C-NMR techniques was ambiguous to assign of 
the location of the azide group.  A very simple and efficient way to differentiate 1,2-diols 
from 1,3-diols lies not on spectroscopic methods, but on organic chemistry.  1,2-diols, 
when treated with HIO4 produce aldehydes which would be very easy to detect. On the 
contrary 1,3-diols do not cleave when reacted with HIO4 (Smith, 2007).  Treatment of the 
azide addition product with HIO4 led to the formation of an aldehyde product (IR 
analysis), which suggested that the azide addition product corresponded to structure 129. 
   
Scheme 32. Reaction of epoxide 127 with sodium azide and subsequent reactions. 
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Further confirmation of the azide addition product was realized when azido-1,2-
diol 129 was then reacted with tosyl chloride, dibutyltin oxide and triethylamine in 
anhydrous DCM to afford mono-tosylated derivative 130 (Martinelli et al., 1999), 
confirmed by analysis of the 1H- and 13C-NMR spectra. Azido tosylate 130 was 
submitted to basic conditions (potassium tert-butoxide) to provide a mixture of three 
compounds, 131-133.  Compound 133 proved to be an epoxide due to its distinct shifts in 
the 1H- and 13C-NMR spectra. The spectroscopic data obtained for compounds 131 and 
132 were diagnostic for isomeric olefins, which led us to the conclusion that epoxide 133 
generated was subject to additional chemical reactions, namely, elimination reactions 
(Scheme 33).  
 
Scheme 33. Proposed mechanism for the formation of elimination products. 
 
 Overall, the picture was clear:  nucleophilic attack of azide on epoxide 127 leads 
to the production of azido-diol 129, being governed by the inductive effect of the 
aromatic ring.   In order to produce the correct azide regioisomer, we chose to install a 
carbonyl pendant to the epoxide ring. The generation of epoxy carboxylic acid 134 
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(Scheme 32), would shift the postition of the nucleophilic attack and provide the desired 
regioisomer 135  (Boger et al., 1994).  
 
Scheme 34. Proposed installment of a carbonyl group. 
In order to capitalize on using carboxylic acid epoxides (e.g., 134) epoxide 127 
required an oxidation.  Three oxidation reactions were attempted and included the use of  
ruthenium chloride and sodium periodate (Denis, et al. 1986), pyridinium dichromate in 
DMF (Boger, et al. 1994) and periodic acid and chromium oxide (Zhao, et al. 1998). 
None of the synthetic methodologies provided the desired carboxylic acid epoxide 134.  
It is noteworthy that Boger applied similar chemical strategy in the total synthesis of 
bouvardin, O-methyl bouvardin and O-methyl-N9-desmethylbouvardin.  In his reported 
syntheses, three distinct methods for the generation of 1,3-diols bearing a 4-iodophenyl 
moiety were also examined: treatment of an epoxy ester with aqueous methylamine, 
reaction of the epoxyalcohol with isocyanate and further hydrolysis of carbamates with 
introduction of an azide using a Sharpless asymmetric dihydroxylation  (Boger & 
Yohannes 1991). Boger’s approach using a Sharpless dihydroxylation was considered, 
but not applied due to the high price of the chiral auxiliary used in the reaction. 
An alternative solution to the problem surfaced, with the realization that chelating 
agents such as trimethylborate can be used to direct nucleophilc attack (Sasaki et al., 
2003). The chelation effect is evident when comparing reactions that use ammonium 
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chloride as a catalyst.  In the trimethylborate-directed reaction (Scheme 33), 
complexation of the borate to the pendant hydroxy group of epoxy alcohol 136 polarizes 
the non-substituted carbon and makes it more reactive as an electrophile, leading to 
azido-1,3-diol products 137.   When this reaction was performed on 127, the anticipated 
azido-1,3-diol 128 was not formed, but rather, the azido 1,2-diol 129.  It appears that 
coordination between boron and oxygen was not suitable to overcome the effect provided 
by the presence of the aromatic ring which prompted us to seek an alternative strategy. 
 
Scheme 35. Use of chelation control in epoxide ring opening reactions.  
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3.3.   Second Synthetic Approach to Bradyoxetin 
Our second approach relied on the direct synthesis of oxteanes from allylic 
alcohols (Scheme 34).   Several precedents guided this approach:  the reactions of allylic 
alcohols with halogenated collidine complexes to generate oxetanes (Homsi & Rousseau 
1999) and the possibility of conducting SN2 reactions on oxetanes with the retention of 
configuration (Jenkinson et al., 2004; Johnson et al., 2004). 
 
Scheme 36. Collidine complexes for the synthesis of oxetanes. 
 
Bis(collidine)bromine(I) hexafluorophosphate (140) was formed from the reaction 
between bromine and bis(collidine)silver(I) hexafluorophosphate (139) (Clausen & Bols 
2000). The silver(I) complex 139 was generated from the reaction of collidine (138), 
silver nitrate and potassium hexafluorophosphate in water (Homsi et al., 2000). The 
reaction of 140 and allylic alcohol 126 afforded a low-yielding mixture of bromo-
59 
 
oxetanes 141. Although the yields were dismal, this reaction represented the first 
successful synthesis of oxetanes whose structures were confirmed by 1H NMR and 13C 
NMR.  Preliminary studies invoking substitution reactions with azide and 141 failed to 
yield substitution products.  The drawbacks of this approach were the low yield of 
oxetane products, the failure of replacing the halogen with an azide group through SN2 
reaction, and the lack of asymmetric control in the synthesis.  This approach was 
abandoned in favor of a more robust synthesis.  
3.4.   Third Synthetic Approach towards Bradyoxetin 
The third approach takes advantage of the stereochemical features inherent in the 
natural product chloramphenicol (142) a broad spectrum antibiotic that was first isolated 
from Streptomyces venezuelae in 1947 (Scheme 35) (Ehrlich et al., 1947).  We 
envisioned that 142 could be transformed into differentially substituted oxetanes 143 and 
144, suitable for a metal-mediated coupling en route to the synthesis of bradyoxetin (23). 
 
Scheme 37.  Chloramphenicol approach for bradyoxetin synthesis.  
 The advantages of using chloramphenicol as a starting material are twofold:  1.) 
it is inexpensive and commercially available, and 2.) it is a chiral starting material whose 
regiochemical configuration is already defined for the formation of aminooxetanes.  
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Furthermore, both enantiomers of choramphenicol and its amide hydrolysis product are 
commercially available.  
The main challenge at hand was to choose a reasonable protecting group strategy. 
The azide group was selected, insofar as it would serve as a latent protecting group for an 
amine during the construction of amino-oxetanes.   Carbamate protecting groups pendant 
to an oxetane ring (e.g., 145), suffer a rearrangement during its attempted removal with 
trifluoroacetic acid, leading to oxazolidines 146 (Scheme 36) (Bach & Schröder 1997; 
Bach & Schroder 1999). Azides possess multiple advantages over other amine protecting 
groups, the most obvious residing its chemical stability to a wide variety of reaction 
conditions (Nyffeler et al., 2002). 
 
 
Scheme 38. Rearrangments of N-Boc oxetanes in the presence of TFA. 
 
 In order to employ an azide as a protecting group, the amine functionality in 
chloramphenicol had to be transformed to the azide.  A robust method for this 
transformation is the diazotransfer reaction (Nyffeler et al., 2002). There are two types of 
diazotransfer reactions described in the literature. The most common is referred to as a 
Regitz diazotransfer reaction (Regitz, 1967) which involves the transfer of a diazo group 
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from a tosyl- or mesyl-azide to an active methylene group.  The methylene group can be 
a part of a 1,3-diketone and the reaction demands the use of a base such as Et3N in order 
to proceed with the formation of an enolate (Scheme 37).  
 
 
Scheme 39. Regitz diazotransfer reaction. 
 
The second type of diazotransfer reaction converts an amino group into an azide, 
using triflic anhydride and sodium azide (triflic azide).   Either aliphatic or aromatic 
amines (Liu & Tor 2003; Yan et al., 2005) can be transformed into azide groups, 
affording an amino surrogate which in turn, can be easily reduced to amines that have 
their configuration retained (Fischer & Anselme 1967; Cavender & Shiner 1972; Vasella 
et al., 1991). The change of solvent and addition of transition metal salts (e.g., Cu(II)) 
have increased the efficiency of this reaction (Alper et al., 1996). Although not obvious, 
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the reagents used in this reaction are extremely safe (previous reactions using 
dichloromethane (DCM) and sodium azide can be dangerous, with the formation of 
unstable diazidomethane (Conrow & Dean 2008). 
The mechanism for this reaction still remains to be confirmed, although a 
dianionic tetrazene has been proposed as one of the key intermediates (Scheme 40) 
(Fischer & Anselme 1967; Nyffeler et al., 2002). 
  
 
 
 
 
 
 
Scheme 40. Proposed mechanism of diazotransfer reaction. 
  
More recently a new methodology for the diazotransfer reaction has been 
developed with the synthesis of an efficient, inexpensive and shelf stable reagent, 
imidazole-1-sulfonylazide hydrochloride (147) (Scheme 41) (Goddard-Borger & Stick 
2007).  
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Scheme 41. Synthesis of imidazole-1-sulfonyl azide hydrochloride (147). 
 
Synthetic approach 3 began with the hydrolysis of chloramphenicol (142) 
(Rebstock et al., 1949) with aqueous NaOH, which afforded the amino 1,3-diol product 
148 in modest yields (Scheme 42). The amine was converted to the azide 149 through the 
use of triflic azide (generated in situ with triflic anhydride and sodium azide in anhydrous 
acetonitrile), copper sulfate and triethylamine in anhydrous acetonitrile. The product was 
selectively tosylated at the primary hydroxyl group with dibutyltin oxide and tosyl 
chloride (Martinelli et al., 1999), affording tosyl azide 150.  
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Scheme 42. Synthesis of azido alcohols using chloramphenicol precursors. 
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The tosyl azide 150 was reacted with potassium tert-butoxide, a standard reagent 
used for oxetane ring synthesis from precursor 3-hydroxy-1-tosylates.  However, repeated 
attempts to form 151 from 150 resulted in the production of intractable mixtures of 
compounds.  Examination of the literature revealed that the nitroaromatic ring could 
suffer vicarious nucleophilic substitutions when treated with potassium tert-butoxide to 
yield products carrying substituents on the para and/or ortho positions (Krylova et al., 
2001); (Makosza & Podraza 2000); (Stalewski, 1998); (Makosza & Kwast 1998); 
(Makosza & Sienkiewicz 1998).  This effect appeared to be limited to the nucleophilic 
tert-butoxide, so in an attempt to obviate this problem, we utilized several non-
nucleophilic bases.  Reactions performed with 150 in the presence of NaH or DBU failed 
to yield the desired oxetane 151 (Scheme 43). Therefore another strategy was conceived 
in order to avoid the undesired reactions that were provoked by the nitro substituent in 
the aromatic ring.   
 
Scheme 43.  Attempted synthesis of oxetanes from azido tosylate precursors. 
  
A logical choice was to reduce the nitro group to an amine after the diazotransfer 
reaction, and then make use of Sandmeyer reaction to manipulate the substituents in our 
favor.  In other words, the reduction would have to be selective to aromatic nitro groups 
leaving the aliphatic azide intact. Several methods for selective reductions were 
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attempted, employing sodium bisulfite or sodium sulfide reducing systems (Park et al. 
1993; Brouillette et al., 2003; Huber et al., 1988). Using literature conditions, reduction 
of 149 provided the desired aniline product 152, in low yields, perhaps due to the 
difficulty associated with purification and product stability (Scheme 44). 
 
Scheme 44. Selective reduction of nitroaromatics to anilines. 
Since these reduction reactions were not effective, a modified approach was 
adopted, where the diazotransfer reaction would be applied to a molecule with two amino 
groups, hence the nitro group would need to be reduced at the beginning of the synthesis.  
 
Scheme 45. Selective diazotransfer reaction. 
Treatment of the chloramphenicol hydrolysis product 148 under standard 
hydrogenation conditions (Pd/C; H2; EtOH) yielded the aniline 153 (Scheme 45).  The 
diazotransfer reaction was conducted on 153 using 1.1 equivalents of triflic azide 
(prepared in situ from triflic anhydride and sodium azide) in the presence of copper 
sulfate and triethylamine, resulting in the formation of aliphatic azide 152 in excellent 
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yield.  To our surprise, the aliphatic amine has a preference over the aromatic amine 
regarding the diazotransfer reaction. Therefore it was possible, using the correct ratio 
between amino substrate and triflic azide, to selectively transform only the aliphatic 
amine into the azide, while sparing the aromatic amine.  Additionally, the use of excess 
triflic azide results in the formation of the bis-azide product 154 (Scheme 46).   
 
 
Scheme 46. Formation of bis-azide 154 from diazotransfer reaction of 153.  
 
The success of the diazotransfer reaction then set the stage for a Sandmeyer 
reaction, where the aromatic amine in compound 152 would be converted to a bromide 
(155), iodide (156), and a nitrile (157) (Scheme 47). We used initially a variant of the 
Sandmeyer reaction, which employs a halodimethylsufonium halide formed in situ from a 
hydrohaloic acid and DMSO (in our case HBr) (Baik et al., 2005). This methodology 
proved beneficial, although the yields were not superior to the traditional Sandmeyer; the 
major drawback involved the product work-up protocols.   
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Scheme 47. Sandmeyer reactions of 152. 
The use of the Sandmeyer reaction to produce both halogenated (Boojamra, 2003) 
and aromatic nitriles (Bühler et al., 2004) was conducted in order to take advantage of 
these functional groups in later coupling reactions.  The Sandmeyer products (155-157) 
were characterized by MS evaluation and 1H and 13C-NMR spectroscopic analysis. 
 
 
Scheme 48. Synthesis of (2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159). 
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The bromo-azide derivative (155) was then subjected to a selective tosylation 
reaction under standard condtions yielding tosyl azide 158; treatment with potassium tert-
butoxide afforded (2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159) in modest yields; 
159 was reduced using Staudinger protocol followed by its conversion to an oxalate 199 
(Scheme 48).  The same set of reaction schemes were used for the synthesis of 4-
((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161) from tosyl azide 160; later reduction of 
161 using Staudinger conditions yielded 4-((2R,3R)-3-aminooxetan-2-yl)benzonitrile; the 
amino oxetane 196 was then converted in an oxalate salt (Scheme 49). The same set of 
reactions were employed for the synthesis of (2R,3R)-3-azido-2-(4-azidophenyl)oxetane 
(163), derived from tosyl azide 162 (Scheme 50). 
 
Scheme 49. Synthesis of 4-((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161) and 4-
((2R,3R)-3-aminooxetan-2-yl)benzonitrile (196). 
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Scheme 50. Synthesis of (2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163). 
 
The use of potassium tert-butoxide in the cyclization reaction afforded low 
product yields due principally to competing reactions, in particular, elimination reactions. 
In an attempt to improve the yield of oxetane products in the cyclization reaction, a series 
of bases were treated with 162 to optimize the product yields.  The use of KN(TMS)2 
(Toyota et al., 2000), n-BuLi (Ito, 1997), LDA (Saphier et al., 2004), KH (Sasaki et al., 
1995), and KH (oil free)/18-crown-6 (Tino, 1987), and Cs2CO3 in DMF (Ameijde & 
Liskamp, 2003) failed to improve the yield of the oxetane product.  Many of the reactions 
were performed in temperatures ranging from -78 oC to room temperature.  It was later 
discovered that potassium carbonate (methanol solvent) was reported to function as an 
effective base in promoting 5-exo-tet-cyclization reactions, documented in the synthesis 
of the tetrahydrofuran-based natural product Jaspine B (Prasad & Chandrakumar 2007).  
Athough carbonate itself is not strong enough to abstract a proton from an alcohol, it has 
been documented that potassium carbonate and methanol generates substantial 
concentrations of CH3OK in situ (Platonov et al. 2002). Treatment of 162 with potassium 
carbonate in methanol afforded a smooth conversion to the oxetane product 163 without 
the formation of elimination products.  The disadvantage of this reaction is the slow rates 
of conversion; on average, reactions were completed in 5 days. 
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The successful synthesis of oxetanes derived from the chloramphenicol hydrolysis 
product prompted us to prepare the enantiomeric series of 159 and 161.  This was easily 
accomplished, since the requisite starting material (164) was commercially available.  
Scheme 49 depicts the five-step protocol for the synthesis of (2S,3S)-3-azido-2-(4-
bromophenyl)oxetane (169). Also following the same procedure depicted on Scheme 46, 
the formation of the bis azide 166 was accomplished (Scheme 51). The overall yield of 
169 was 13.5% from 164. 
 
Scheme 51. Formation of bis-azide 166 from diazotransfer reaction of 165. 
 
Scheme 52. Synthesis of (2S,3S)-3-azido-2-(4-bromophenyl)oxetane (170). 
 In a similar fashion, the nitrile Sandmeyer product 171 was converted to 4-
((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173) (Scheme 53).  Final oxetane products and 
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intermediates were characterized by 1H and 13C-NMR analysis.   Optical rotation data 
also confirmed that stereochemical integrity was preserved through the synthesis.   
 
 
Scheme 53.  Synthesis of 4-((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173). 
Mitsunobu reactions were employed as a means to invert the configuration of the 
carbon bearing the hydroxy group.  This allowed for the expedient synthesis of the 
diastereomeric series of compounds.  Briefly, 4-bromophenyl- and 4-cyanophenyltosyl 
azides (169 and 172 respectively) were treated with DIAD, triphenylphosphine and p-
nitrobenzoic acid.  This afforded p-nitrophenyl esters 174 and 176.  Reaction of these 
esters with potassium carbonate in methanol afforded the oxetane products directly (via 
the initial ester hydrolysis and subsequent cyclization, Scheme 54). The products were 
characterized as (2R,3S)-3-azido-2-(4-bromophenyl)oxetane (175) and 4-((2R,3S)-3-
azidooxetan-2-yl)benzonitrile (177). 
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Scheme 54. Mitsunobu reactions in the synthesis of 175 and 177. 
 
With the successful construction of oxetanes with defined stereochemical 
conformation and requisite functional groups, the next step was considered.  It was 
envisioned that a Grignard reaction could be conducted by the reaction of magnesium 
with arylbromide 159 and subsequent reaction with nitrile 161, leading to bradyoxetin 
precursor with defined stereochemical configuration about the oxetane ring (Scheme 55).  
If successful, this reaction would be applied to the other stereoisomeric sets of 
arylbromides and arylnitriles precursor oxetanes.  
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Scheme 55.  Grignard reaction for bradyoxetin synthesis. 
Consideration was given to the notion that the azide group may not be compatible 
under Grignard reaction conditions.  However, several examples were identified in the 
literature which suggested otherwise (Scheme 56).   
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Scheme 56. Grignard reactions of organomagesium reagents to molecules containing 
an azide group. 
 
Reaction of oxetane 159 with magnesium in anhydrous THF was first investigated 
on a small scale to determine whether magnesium would insert and form a stable reagent 
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(e.g., 178) to add to nitrile 161 and form the imine product (Fergus et al., 2004).  Aliquots 
of the reaction mixture were taken at various time points, and quenched with dilute acid 
(Scheme 57). If the magnesium insertion was successful, (2R,3R)-3-azido-2-
phenyloxetane (179) would have been produced.  Unfortunately, this product was not 
identified in the reaction mixture.      
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Scheme 57. Attempts at forming Grignard reagent 178. 
 Since the insertion of magnesium was not occurring, it seemed appropriate to look 
for a more robust method in the literature.  An elegant solution was to catalyze the 
Grignard reaction with lithium salts, like LiCl. For example, reaction of  4-bromoanisole 
with i-PrMgCl (without additive) affords the magnesium insertion product in 18% yield, 
but the same reaction in the presence of the additive LiCl, the magnesium insertion 
product yield increases to 84% . The reaction is believed to proceed with the formation of 
a complex, i-PrMgCl-LiCl, which later catalyzes the Br/Mg exchange reaction (Scheme 
58) (Krasovskiy & Knochel 2004). 
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Scheme 58. Catalysis of the Br/Mg exchange reaction with LiCl. 
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A solution of  i-PrMgCl-LiCl complex (generated in situ by the addition of a 
solution of i-PrMgCl in THF to LiCl) was prepared, and a solution of (2R,3R)-3-azido-2-
(4-bromophenyl)oxetane (159) was added dropwise and stirred at room temperature for 6 
hours. Confirmation of the Mg insertion was established by quenching an aliquot of the 
reaction mixture with NH4Cl, which yielded the “naked” phenyloxetane 179 (Scheme 
59). 
 
 
Scheme 59.  Successful Mg insertion reactions using LiCl additives.  
 Once the magnesium insertion reaction was confirmed, the reaction was applied 
towards the synthesis of bradyoxetin, as depicted earlier in Scheme 55.  However, no 
products were formed as a result of Grignard addition to the nitrile (recovered starting 
material).  This reaction was repeated under a variety of conditions, with changes in 
solvent, temperature, and reaction time. 
 
3.5   Approaches towards the synthesis of oxetin 
 The lack of success in the final stages of bradyoxetin synthesis prompted us to 
examine approaches for the synthesis of other oxetane, namely, the oxetin series of 
compounds.  This approach was based on the fact that aromatic rings can serve as 
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carboxylic acids precursors via oxidative degradation reactions in the presence of 
ruthenium salts (Scheme 60).  We believed that a number of our “bradyoxetin” 
intermediates could be used for the direct synthesis of oxetin stereoisomers. 
 
Scheme 60. Retrosynthetic strategy for the synthesis of oxetin (stereochemistry not 
defined). 
 
 Oxidative degradation of aromatic rings with ruthenium salts produce carboxylic 
acids with overall retention of configuration.  Some examples that have successfully been 
employed in the oxidative conversion of aromatic rings to carboxylic acids are depicted 
in Scheme 61.    
 
Scheme 61. Application of oxidative degradation reactions. 
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 The RuCl3 oxidizing system has been used successfully with a variety of aryl 
substrates including: 2-chloroquinoline (Cho et al., 2004), p-methoxybenzene (Burke & 
Voight 2000),  3,4-dimethoxybenzene (Kalvin & Woodard 1985), 2,5-dimethoxybenzene 
(Sarma & Chattopadhyay 1982), and acetylated anilines (Wu & Mosher 1986).  Not all 
aromatic groups are suitable for degradation with Ru catalysts. 
The mechanism of the oxidative decarboxylation reaction is illustrated in Figure 
24. The first step for the initial cleavage of the aromatic double bond has been 
extensively documented.  The Ru(VIII) is generated in situ by using a catalytic amount of 
RuCl3 and NaIO4 (generally added in a large quantity when compared to the 
stoichiometry). The Ru(VIII) is therefore constantly regenerated. The first product of the 
oxidation is the α−ketoaldehyde (A) which is subsequentially converted to the aldehyde 
hydrate (B) in aqueous media. The hydrate (B) is further oxidized to the keto acid (C), 
and undergoes a second hydration reaction leading to intermediate (D).  Reaction with 
Ru(VIII) species leads to the obligatory pentacyclic ruthenium intermediate (E).  
Breakdown of this complex produces the product carboxylic acid (F) and loss of carbon 
dioxide (Bruckner, 2010).   
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Figure 24: Proposed mechanism for oxidative cleavage of aromatic 
compounds with RuCl3 and NaIO4.  
 
 Similar oxidative degradation reactions have been reported for the synthesis of 
oxetane carboxylic acids (181), formed from the reaction of 180 with RuCl3/NaIO4 in 
CH3CN/ethyl acetate/H2O (Scheme 61) (Albert et al., 2001). 
 
Scheme 62. Oxidative cleavage reaction of a 2-phenyl oxetane derivative. 
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 Initially, we focused our attention to oxetanes that we produced as intermediates 
for the total synthesis of bradyoxetin.  The first oxetane selected for the oxidative 
cleavage reaction was was (2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163) (Scheme 63), 
since it was a side-product formed from a large scale diazotransfer reaction. 
 
Scheme 63.  Oxidative cleavage of oxetane 163. 
 
 The result of the oxidative cleavage reaction was unusual, insofar as the only 
product isolated from the reaction mixture was 4-azidobenzoic acid (182). The oxidation 
reaction cleaved the oxetane ring rather than the aromatic ring. A survey of the literature 
shed light regarding this unusual oxidation; it appears that certain functional groups 
located on the aromatic ring are not suitable for oxidative degradation reactions. A pilot 
reaction with compound 152 (Scheme 64) was performed, by initially acetylating both 
the amino and hydroxyl substituent, affording 183. This acetylated derivative was 
submitted to the oxidative cleavage reaction using RuCl3/NaIO4. In this example, the 
oxidative cleavage reaction was successful, clearly substantiating the influence of 
functional group effects on the aromatic ring. 
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Scheme 64.  Oxidative cleavage reaction of 182 with RuCl3 and NaIO4.  
 The next logical step was to convert the 4-azido oxetane 163 into the 4-amino 
oxetane 185 by catalytic hydrogenation (Scheme 65).  Monitoring of the reaction 
progress by TLC and MS evaluation suggested that 185 was being formed during the 
hydrogenation reaction. However, attempts at isolating 185 from the reaction mixture 
failed; a black intractable material was formed upon repeated attempts, possibly due to 
the 4-amino groups participation in oxetane ring opening reactions.   
 
Scheme 65. Attempted reduction of bis-azide 163.  
 A second option for the production of oxetin stereoisomers using the oxidative 
cleavage reaction invoked the use of oxetanes bearing an unsubstituted aromatic ring. To 
our favor, the amino diol lacking functionality on the aromatic ring (compound 186) had 
become commercially available for the first time.  Compound 185 was subjected to the 
same set of reaction protocols that we developed for bradyoxetin intermediates (Scheme 
65).  Briefly, a diazotransfer reaction afforded 186, selective tosylation yielded 187, and 
cyclization with potassium carbonate in methanol generated (2R,3R)-2-phenyloxetan-3-
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amine (187) (the same compound produced during our investigation of the magnesium 
insertion reaction with arylbromide oxetane 159).  Cyclization reactions of 188 using 
potassium tert-butoxide failed to produce oxetane 179, and instead, afforded elimination 
products. 
 
Scheme 66. Synthesis of (2R,3R)-2-phenyloxetan-3-amine (179). 
  
 Reaction protocols were repeated for the synthesis of the remaining isomers of 2-
phenyloxetan-3-amine (190, 193, and 195) (Scheme 67). Since Mitsunobu reaction 
conditions require the use of triphenylphosphine (188 to 189 and 190 to 194), it was 
imperative that the PPh3 was completely reacted with the DIAD reagent, since PPh3 
reacts with azides in the Staudinger reaction to form  iminophosphoranes (Solsona et al., 
2003).  
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Scheme 67. Synthesis of chiral 2-phenyloxetan-3-amines. 
2-phenyloxetan-3-azides 179 and 195 were submitted to oxidative cleavage 
reactions using RuCl3/NaIO4 in acetonitrile/water (Scheme 68).  The only product 
isolated from the reaction mixture was benzoic acid.  
 
 
 
 
Scheme 68. Oxidative cleavage reactions of 2-phenyloxetan-3-amines. 
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3.6 Conclusions 
 This research describes the evolution on the understanding of some of the quorum 
sensing pathways and how some of chemical signals can, in different species, trigger 
different phenotypic responses. The objectives were tailored to synthetic chemistry 
approaches, with the purpose of elucidating the absolute configuration of bradyoxetin. 
 Regarding conclusions concerning the stereochemistry of bradyoxetin, further 
experiments are required, but several insights into the possible relative configuration of 
the structures can be inferred.  The reported coupling constants obtained from evaluation 
of the 1H NMR spectrum between H1 and H2 of bradyoxetin is 2.95 Hz (Loh et. al., 
2002) while the coupling constants for the same set of protons in compound 196 is 6.8 
Hz.  It appears that the imine bridge between the aromatic rings exerts a larger influence 
on the protons H1 and H2 than anticipated. The azido oxetanes do not differ to a large 
extent when comparing the coupling constants from the amino oxetanes.  The difference 
between 161 and 196 was only 0.1 Hz. The synthesized oxetanes offer a better model for 
the evaluation than the oxetanes described in the seminal article. They possess a closer 
structure than the ones obtained through Paterno-Buchi, which lack a para-substituent and 
possess an amide rather than an amine or an azide; their coupling constants are on the 
order of 7Hz. Trans-substituted oxetanes possess smaller coupling constants when 
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compared to cis-substituted analogs; the values are still large compared to bradyoxetin. 
 
Figure 25. Oxetanes and their coupling constants  
 Some new insights into oxetane synthesis have been achieved and a new option 
has been disclosed for using chloramphenicol and its derivatives as chiral building 
blocks.  Approaches were also developed for the synthesis of the natural product oxetin, 
using aromatic rings as carboxylic acids surrogates with retention of configuration. 
Although the completion of both bradyoxetin and oxetin was not achieved, an efficient 
route for the synthesis of oxetin has proposed and nearly accomplished, and a new 
synthesis of bradyoxetin has been proposed and its total synthesis is on the horizon. It has 
been also determined that aliphatic amines are more prone to diazotransfer than aromatic 
amines. The inverse was also tested, with aromatic azides being selectively reduced in the 
presence of aliphatic azides. 
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 The future of this research can surely be expanded with the investigation of 2-
phenyl-3-amino oxetanes as CNS agents, since they share a striking resemblance with 
katinone, methamphetamine and other derivatives such as bupropion. The methylation of 
the amine can be achieved by following a protocole described in the literature (Sayyed & 
Sudalai, 2004). 
  
 
 
 
 
 
 
 
 
 
 
Figure 26. Proposed methylation of aminooxetanes and rationale based on 
cathinone. 
 
The intermediates obtained through Mitsunobu reaction also can be easily 
manipulated with a suitable nucleophile to diversify the construction of hetereocycles 
other than oxetanes. As an example, azetidines can be obtained as demonstrated in the 
prior literature (Tatibouet et al., 2001; Sajjadi et al., 2001). 
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Scheme 69. Proposed synthesis of azetidine derivatives based on Mitsunobu 
intermediates. 
 
By providing a cheaper and shorter route to oxetin, the investigation of oxetin as 
an amino acid surrogate in oligopeptides that carry serine, as an example, would be 
feasible. The study of bradyoxetin on quorum sensing systems other than rhizobium, as 
well as the study of bradyoxetin fragments on such pathways is worthy of  pursuit. 
Some of the challenges met in this dissertation research should be considered as 
opportunities for future research. The regiocontrol of epoxide opening, stereocontroled 
bromonium mediated reactions, and a comprehensive study on aromatic oxidative 
degradation are ripe for study.         
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CHAPTER 4: EXPERIMENTAL 
4.1 General Methods 
 
                All commercially available starting materials and reagents were purchased 
from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.  THF and diethyl ether were 
distilled from sodium-benzophenone ketyl.   Analytical TLC plates (silica gel) were 
purchased from Sorbent Technologies (G Series-UV 254).  Silica gel column 
chromatography was conducted using standard chromatography grade silica gel, 20-63 
µM particle size, (Sorbent Technologies).  Analytical TLC plates (alumina-B F-254-200 
micron plates) were purchased from Selecto Scientific.  1H NMR and 13C NMR spectra 
were recorded at either 400 or 500 MHz on a Bruker Avance DRX spectrometer.  The 2D 
NMR COSY, HMBC, HMQC, and NOESY were recorded at 500 MHz (Bruker Avance 
DRX) or 600 MHz NMR (Varian).  Elemental Analysis was obtained using a 
PerkinElmer 2400 Series II CHNS/O Analyzer.  Low-resolution mass spectrometry 
analysis was performed using a Waters ZQ single-quadrupole system using either ESI 
positive (ESI+) or ESI negative (ESI-) electrospray ionization.  High-resolution mass 
spectrometry (HRMS) was recorded using a Micromass Q-TOF micro instrument.  HPLC 
analysis was conducted with a Waters Delta Prep 4000 System with 7725I Rheodyne 
injector and Water 2487 Dual Wavelength Absorbance Detector.  FTIR were measured 
using a Bruker Vector 33 system.   Optical rotations were obtained with a Rudolph 
Autopol IV polarimeter at λ=589 nm. 
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4.2  Synthetic Procedures and Compound Data 
Ethyl (E)-4-iodo cinnamate (125). Ester 125 was prepared 
from 4-iodobenzaldehyde (123, 1.00 g, mmol) and 
carbethoxymethylene triphenylphosphorane (124, 1.8 g, 
mmol) in benzene, under reflux for 4 hours on a RBF. After the reaction was completed 
the solvent was evaporated and the residue was purified using silica gel column 
chromatography (95% hexanes-5% EtOAc) to yield 125 (90%). 1H NMR (400 MHz, 
CDCl3): δ 7.70 (d, 2H, J = 8.5Hz), 7.57 (d, 1H, J = 16Hz), 7.23 (d, 2H, J = 8.5Hz), 6.42 
(d, 1H, J = 16Hz), 4.25 (q, 2H, J = 7.1Hz), 1.33 (t, 3H, J = 7.1Hz). 
 
 (E)-3-(4-Iodophenyl) prop-2-en-1-ol (126).   A solution of 
ethyl (E)-4-iodo cinnamate (125, 8.24 g, 27.2 mmol) in 
anhydrous CH2Cl2 (100 mL) was treated with i-Bu2AlH (82 mL, 1.0 M hexane solution, 
82 mmol, 3.0 equiv) in three portions at -78oC , and the mixture was stirred at -78oC for 
20 min. The reaction mixture was quenched by the addition of CH3OH (25 mL), warmed 
to 25oC, diluted with saturated aqueous sodium potassium tartrate (100 mL), and 
partitioned. The aqueous phase was extracted with CH2C12 (4 X 100 mL), and the 
combined organic layers were washed with saturated aqueous sodium potassium tartrate 
(150 mL), dried over Na2SO4, and concentrated in vacuo. Flash chromatography (silica 
gel, 5 X 20 cm, 20-40% EtOAc-hexane) afforded 126 (7.07 g, 95%) as a white crystalline 
solid: mp. 108-110 oC (1:2 EtOAc-hexane, white needles); 1H NMR (CDC13, 400 MHz) 
δ 7.63 (d, 2H, J = 8.4 Hz, Ar C3- and C5-H), δ 7.10 (d, 2H, J = 8.4 Hz, Ar C2- and C6-
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H), δ 6.53 (d, 1H, J=15.8Hz, C3-H), 6.36 (dt, lH, J=5.4, 15.8 62.5 MHz) 13C NMR 
(CDC13, 101 MHz) δ 137.7, 136.2, 129.9, 129.4, 128.2, 92.9, 63.5; IR (neat) v-3310, 
2926, 2847, 1651, 1478, 1395, 1084, 1060, 1006, 971, 848, 799, 774 cm-1. 
 
 (2S,3S)-2-(Hydroxymethyl)-3-(4-iodophenyl)oxirane (127).   
A solution of 126 (7.49 g, 26.0 mmol) in anhydrous CH2C12 (250 
mL) containing activated powdered 4-A molecular sieves (25 g, 1 g/mmol) was treated 
sequentially with (+)-diisopropyl L-tartrate (457 mg, 1.9 mmol, 0.41 mL, 0.075 equiv) 
and Ti(O-i-Pr)4 (314 mg, 1.30 mmol, 0.33 mL, 0.05 equiv) at -20oC (30 min). After 
reagent aging was complete, t-BuOOH (3.5 M CH2Cl2 solution, 52.0 mmol, 14.9 mL, 2.0 
equiv) was added dropwise (15 min). After 4 h, the mixture was warmed from -20 to 0 oC 
(20 min), quenched by the addition of H2O (25 mL), and allowed to warm to 25oC (45 
min). Aqueous NaOH (25%) (20 mL) was added and the mixture stirred at 25oC (45 
min). Following the addition of CH3OH (10 mL), the aqueous phase was extracted with 
CH2Cl2 (3 X 50 mt), dried (Na2SO4), and concentrated in vacuo.  Flash chromatography 
(SiO2, 20-50% EtOAc-hexane) afforded 127 (3.21 g, 45%) as a white solid.  mp. 80-82 
oC.  [α]25D -39.0  (c=1.0, MeOH).   1H NMR (CDCl3, 400 MHz) δ 7.67 (d, 2H, J = 8 Hz, 
Ar C3- and C5-H), 7.02 (d, 2H, J=8 Hz, Ar C2-and C6-H), 4.03 (ddd, 1H, J=2.0 12.9 Hz, 
C1-H), 3.88 (d, 1H, J= 5.1 Hz, C3-H), 3.80 (ddd, 1H, J = 3.6, 7.6, 12.9 Hz, C1-H), 3.16 
(m, 1H, C2-H), 1.85 (t, 1H, J = 6.2 Hz, OH); 13C NMR (CDC13, 101 MHz) δ 137.63, 
136.53, 127.57, 93.72, 62.39, 61.00, 55.0. 
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 (2R,3R)-3-azido-3-(4-iodophenyl)propane-1,2-diol (129). 
1786 mg of epoxide 126, NaN3 (4.14 g) and NH4Cl (1.53 g) 
were dissolved in MeOH (12 ml) and water (2 ml) and heated to 
112 oC, until the reaction was complete (the reaction was monitored using TLC). The 
reaction mixture was evaporated and the residue was extracted with EtOAc. The phases 
were separated and the aqueous phase was extracted with EtOAc. The combined organic 
phases were washed with brine, dried over Na2SO4, concentrated and purified by silica 
gel column chromatography (isocratic diethyl ether:petroleum ether) [9:1]. (Yellow oil, 
yield 78%) [α]25D -187.20 (c=1.0, CHCl3). IR (CHCl3):ν  3385, 2930, 2104, 1647, 1587, 
1541, 1485, 1400, 1249, 1040, 814, 453 cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.73 (d, 2H, 
J = 8 Hz, Ar C3- and C5-H), 7.08 (d, 2H, J=8 Hz, Ar C2-and C6-H), 4.52 (d, J = 6.8 Hz, 
1H), 3.75 (s, 1H), 3.59 (m, 2H), 2.72 (s, 2H); 13C NMR (CDCl3, 100 MHz): δ 62.84, 
66.49, 73.88, 94.62, 129.68, 135.84, 138.08. ESIMS+; 342 (M++ 23), 661 (2M++ 23). 
 
Reaction of tosyl derivative 130 with KOtBu   Potassium tert-butoxide (0.6 g) was 
slowly added to a solution of the tosylate 130 (1.8 g) in anhydrous DCM at 0oC. The 
reaction was monitored by TLC (70% diethyl ether: 30% petroleum ether). After 
completion the reaction was quenched with water. The organic phase was extracted with 
DCM and dried over Na2SO4. The organic phase was then separated and evaporated. 
Purification of two product bands 131/132 (mixture) and 133 was accomplished using 
silica gel chromatography (gradient of diethyl ether:petroleum ether [5:95to 50:50].  
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 (R)-2-((R)-azido(4-iodophenyl)methyl)oxirane (133)  [α]25D -
132.20 (c=1.0, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 7.76 (d, J = 
8.5Hz, 2H), 7.13 (d, J = 8.5Hz, 2H), 4.57 (d, J = 4.5 Hz, 1H), 3.23–
3.21 (m, 1H), 2.88-2.85 (m, 1H); 13C NMR (CDCl3, 101 MHz): δ 44.83, 53.61, 64.70, 
94.62, 129.17, 135.53, 138.03. FTIR (CHCl3) ν 2103, 1647, 1587, 1541, 1486, 1398, 
1296, 1061, 837, 452 cm-1; ESIMS (+): 301(MH+). 
 
(Z)-3-azido-3-(4-iodophenyl)prop-2-en-1-ol 
(132) and (E)-3-azido-3-(4-
iodophenyl)prop-2-en-1-ol (131) (Major E 
isomer listed).13C NMR (CDCl3, 100 MHz): 58.16, 95.20, 118.83, 128.74, 130.73, 
133.85, 138.01. 
 
Attempted synthesis of (2R,3S)-3-(4-iodophenyl)oxirane-2-
carboxylic acid (134)  
Method 1.  To a vigorously stirred mixture of the epoxy alcohol 127 (276 mg, 1 mmol) 
in 2 mL of carbon tetrachloride, 2 mL of acetonitrile, and 3 mL of water was added 
sodium bicarbonate (0.42 g; 5 mmol), and sodium periodate (0.642 g ,3 mmol).   
Ruthenium trichloride trihydrate (7.5 mg, 33 µmol) was then added. The mixture was 
stirred at 20 oC for 44 h, after which the acidic material was extracted at 0 oC carefully 
into diethyl ether and the organic layer dried over sodium sulfate. The ethereal fraction 
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was submitted to acid-base work up. No oxidation product was detected by either ESI(-)-
MS or 13C-NMR analysis. 
Method 2.   Ruthenium trichloride trihydrate (0.0075 g, 33 µmol) was added to a stirring 
biphasic mixture of epoxy alcohol 127 (0.15 g, 1 mmol), sodium periodate (0.642 g, 3 
mmol), and sodium bicarbonate (0.42 g, 5 mmol) in CCl4 (2 mL), acetonitrile (2 mL), and 
water (3 mL). After 42 h of stirring, an additional quantitity of RuCl3 (0.0076 g, 34 µmol) 
and sodium periodate (0.157 g, 0.72 mmol) were added and the stirring was continued for 
1 h to complete the reaction. Then, DCM (8 mL) was added followed by a small amount 
of water (until phase separation occurred). The pH of the water layer was adjusted to 4.0 
and the aqueous layer was extracted with DCM. Acidification and extraction were 
repeated until the pH remained constant. The combined layer was dried over Na2SO4 and 
solvent evaporated.  No oxidation product was detected by either ESI(-)-MS or 13C-NMR 
analysis. 
Method 3 A solution of 127 (250 mg, 0.90 mmol) in anhydrous DMF (4.0 mL) was 
treated with PDC (1.10 g, 2.87 mmol, 3.5 equiv) at 25 oC. After 5 h, additional PDC (348 
mg, 0.90 mmol, 1.0 equiv) was added. The reaction mixture was stirred at 25 oC for an 
additional 5 h before the addition of H2O (50 mL) and EtOAc (50 mL). The aqueous 
phase was extracted with EtOAc (4 X 50 mL), and the combined organic layers were 
washed successively with H2O (3 X 75 mL) and brine (3 X 75 mL).  The organic layer 
was dried over Na2SO4 and concentrated in vacuo. The crude residue was dissolved in 
saturated aqueous NaHCO3 (10 mL) and EtOAc (10 mL). The organic phase was further 
extracted with saturated aqueous NaHCO3 (3 X 10 mL), and the combined aqueous layers 
were acidified to pH 4 with the addition of 5% aqueous HCl and extracted with EtOAc (4 
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X 20 mL). The combined organic phase was washed with H2O (3 X 20 mL) and saturated 
aqueous NaCl (3 X 20 mL), dried (Na2SO4), and concentrated in vacuo. No oxidation 
product was detected by either ESI(-)-MS or 13C-NMR analysis. 
Method 4.   A stock solution of H5IO6/CrO3 was prepared by dissolving H5IO6 (11.4 g, 
50 mmol) and CrO3 (23 mg, 1.2 mol %) in wet MeCN (0.75 v % water) to a volume of 
114 mL (complete dissolution typically required 1-2 hours). The H5IO6/CrO3 solution 
(11.4 ml) was then added to a solution of the alcohol 127 (2.0 mmol) in wet acetonitrile 
(10 mL, 0.75 v % water) in 30-60 minutes while maintaining the reaction temperature at 
0-5 °C. The mixture was aged at 0 °C for 0.5 h and the completion of the reaction was 
confirmed by ESIMS. The reaction was quenched by adding an aqueous solution of 
Na2HPO4, (0.60 g in 10 mL of H2O). Ethyl acetate was added and the organic phase was 
submitted to acid-base work-up.  The organic layer was separated and dried over Na2SO4. 
No oxidation product was detected by either ESI(-)-MS or 13C-NMR analysis. 
 
Bis(2,4,6-trimethylpyridine)silver(I) hexafluorophosphate (139).  
A 2-L, three-necked, round-bottomed flask was equipped with a 
mechanical stirrer and a 250-mL pressure-equalizing dropping funnel. 
The flask was charged with 1 L of distilled water, 100 g of silver nitrate 
(0.588 mol) and 109.3 g of potassium hexafluorophosphate (0.594 mol) 
When all the solids were dissolved, 221 mL of 2,4,6-collidine (1.67 mol) was added over 
10 min with stirring.  Technical grade 2,4,6-collidine can be used after purification by 
distillation from calcium hydride CaH2.  A slight exothermic reaction was observed, 
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corresponding to the formation of a white solid. The mixture was stirred for 1 hr at room 
temperature, the solid was suction filtered, and the filter cake was washed with 1 L of 
water. The solid was dried in the dark in a desiccator under high vacuum over phosphorus 
pentoxide (P2O5) for 1 week, to afford 262 g (90%) of the silver salt as a white-gray 
solid, mp. 210°C. 
 
Bis(2,4,6-trimethylpyridine)bromine(I) hexafluorophosphate (140). 
A 1-L, three-necked, round-bottomed flask equipped with a mechanical 
stirrer, a 50-mL pressure-equalizing addition funnel, and a drying tube 
containing calcium chloride was charged with 500 mL of dry DCM, and 
82.5 g of bis(trimethylpyridine)silver(I) hexafluorophosphate (139, 
0.166 mol). Then, 8.3 mL of bromine (0.161 mol) was added over a period of 10 min. 
The mixture was stirred until all the bromine was consumed (1 hr) [Note: all of the 
bromine should be consumed before removal of the solvent]. The resulting yellowish 
solid (silver bromide) is suction filtered and washed with 100 mL of anydrous DCM. The 
filtrate was concentrated on a rotary evaporator at a maximum bath temperature of 30°C 
to give 65 g (83%) of bis(2,4,6-trimethylpyridine)bromine(I) hexafluorophosphate (140) 
as a white solid (mp. 127-128°C). This solid must be stored in the dark at 0°C.  
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3-bromo-2-(4-iodophenyl)oxetane (141).  To bis(collidine)bromine(I) 
hexafluorophosphate (140, 0.71 g, 1.5 mmol) in DCM (30 mL) was 
added a solution of allylic alcohol 126 (1.2 mmol) and 2,4,6-collidine 
(0.15 g, 1.2 mmol) in DCM (10 mL) over 6 h. Subsequently, silica gel (2 g) was added 
and the solvent was removed. The product was purified by flash chromatography over 
silica gel using an initial gradient of petroleum ether 100% which was increased to 
diethyl ether 20%-petroleum ether 80% affording oxetane 141 as an oil (6% yield) 1H 
NMR: δ 3.92 (dd, J = 7.6 Hz, 1H); 4.26 (m, 1H), 4.47 (dd, 1H), 4.75 (d, 10 Hz, 1H), 7.72 
(d, J = 8 Hz, 2H), 7.16 (d, J = 8 Hz, 2H). 13C NMR: δ 42.90, 76.34, 91.38, 94.60, 127.00, 
137.88, 138.208. 
 
 (1R,2R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol (148). 
Chloramphenicol (142) (3.0 g) was treated with 200 mL of 0.1 
M aqueous NaOH at room temperature for 18 h. The solution 
was filtered and the white solid was washed with water and dried over P2O5 (high 
vacuum) yielding hydrolysis product 148 (mp.161-162 oC): [α]25D -23.3o (c=3.0, MeOH). 
Literature reported melting point and optical rotation are both in agreement with our 
synthesized compound.  
 
General procedure for diazotransfer reactions. 
 A typical experimental procedure for the preparation of triflyl azide was as follows: a 
suspension of sodium azide (436 mg, 6.70 mmol) in 8 mL of acetonitrile (pyridine) was 
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cooled in ice bath. Triflic anhydride (1.57 g, 5.56 mmol) was added by syringe at 0 oC 
over a 5 minute period.  The reaction was stirred  for 2 h at 0 oC ,  and the TfN3- solution 
(filtration of the salts can be done if necessary) was added directly to the amine solution 
for the subsequent diazotransfer reaction. 
 
General procedure for the reaction of triflic azide with amines. For organic soluble 
substrates, 1.0 g of substrate was dissolved in 5 mL of acetonitrile (pyridine). In case of 
saline substrates, water was employed.  CuSO4 (1 mole %) and NEt3 (2 equilalents per 
substrate amine) were added to the solution while stirring. The mixture was cooled in an 
ice bath, followed the by the dropwise addition of an acetonitrile solution of triflyl azide 
(1.2 equiv per amino group, based on the amount of triflic anhydride used in the 
preparation of TfN3). The reaction mixture was allowed to warm to room temperature. A 
homogeneous solution could be obtained after the addition of triflyl azide, and the 
reaction normally is completed within 12 h. The reaction was monitored by TLC. After 
its completion the solvent was removed by rotary evaporation and the crude product was 
purified using silica gel chromatography. The purification proved to be difficult, mainly 
due to the co-elution of a by-product derived from triflic anhydride. Multiple 
purifications by column chromatography were performed in some instances.   
 
 
 (1R,2R)-2-azido-1-(4-nitrophenyl)propane-1,3-diol (149).  
Oil. IR (CHCl3): ν 3369, 2109, 1604, 1518, 1349, 1194, 1082, 
857, 772, 702 cm-1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J = 
O2N
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8.8 Hz, 2H), 7.60 (d, J = 8.8 Hz, 2H), 5.04 (d, J = 4.4 Hz, 1H), 3.59 (dd, J = 11.6, 4.0 Hz, 
1H), 3.71 – 3.67 (m, 1H), 3.44 (dd, J = 9.2, 5.2 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C 
NMR (100 MHz, CDCl3) δ 147.55, 127.36, 123.83, 106.44, 73.73, 67.91, 62.76.  
HRESI+MS: (C9H10N4O4Na) Calc: 261.0600. Found: 261.0587. 
 
(1R,2R)-2-azido-1-(4-azidophenyl)propane-1,3-diol (154).  
Oil. [α]25D -90.00 (c = 1.0, CHCl3); 1H NMR (400 MHz, 
MeOD) δ 7.42 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 
4.73 (d, J = 6.0 Hz, 1H), 3.59 (dd, J = 11.0, 3.5 Hz, 1H), 3.55 – 3.48 (m, 1H), 3.44 (dd, J 
= 11.0, 7.0 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C NMR (100 MHz, MeOD) δ 140.93, 
140.05, 129.30, 119.93, 74.15, 70.80, 62.95. HRESI-MS: (C9H10N6O2Na) Calc: 
257.0763. Found: 257.0769. 
 
(1S,2S)-2-azido-1-(4-azidophenyl)propane-1,3-diol (165). 
Oil. [α]25D +87.00 (c = 1.0, CHCl3) 1H NMR (400 MHz, 
MeOD) δ 7.42 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 
4.73 (d, J = 6.0 Hz, 1H), 3.59 (dd, J = 11.0, 3.5 Hz, 1H), 3.55 – 3.48 (m, 1H), 3.44 (dd, J 
= 11.0, 7.0 Hz, 1H), 2.65 (s, 1H), 2.15 (s, 1H). 13C NMR (100 MHz, MeOD) δ 140.93, 
140.05, 129.30, 119.93, 74.15, 70.80, 62.95. 
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(1R,2R)-1-(4-aminophenyl)-2-azidopropane-1,3-diol (152).  
Oil.  [α]25D -66.00 (c = 1.0, CHCl3); 1H NMR (400 MHz, 
MeOD) δ 7.13 (d, J = 8.4 Hz, 2H), 6.72 (d, J = 8.4 Hz, 2H), 
4.84 (s, 1H), 4.53 (d, J = 7.2 Hz, 1H), 4.11 (q, J = 7.1 Hz, 1H), 3.76 (s, 2H), 3.74 – 3.41 
(m, H), 3.41 – 3.18 (m, 23H), 2.02 (s, 21H), 1.24 (t, J = 7.1 Hz, 22H). 13C NMR (101 
MHz, MeOD) δ 148.62, 132.02, 128.57, 116.40, 74.90, 71.30, 63.11.  HRMS: 
(C9H13N4O2) Calc: 209.1039. Found: 209.1039. 
 
 (1S,2S)-1-(4-aminophenyl)-2-azidopropane-1,3-diol (167).  
Oil. [α]25D +68.60 (c =1, CHCl3); 1H NMR (400 MHz, MeOD) 
δ 7.13 (d, J = 8.3 Hz, 2H), 6.72 (d, J = 8.4 Hz, 2H), 4.53 (d, J 
= 7.2 Hz, 1H), 4.11 (q, J = 7.1 Hz, 1H), 3.58 – 3.44 (m, 2H), 3.43 – 3.27 (m, 2H), 2.02 (s, 
2H), 1.24 (t, J = 7.1 Hz, 2H). 13C NMR (100 MHz, MeOD) δ 148.60, 132.04, 128.57, 
116.41, 74.90, 71.30, 63.11.  HRMS: (C9H12N4O2Na) Calc: 231.0858. Found: 231.0853. 
 
(1R,2R)-2-azido-1-phenylpropane-1,3-diol (187). Colorless oil. 
[α]25D -80.40 (c =1, CHCl3); 1H NMR (400 MHz, MeOD) δ 7.40 
(ddd, J = 14.5, 7.9, 4.2 Hz, 4H), 7.35 – 7.28 (m, 1H), 4.74 (d, J = 
6.0 Hz, 1H), 3.64 – 3.54 (m, 2H), 3.48 (ddd, J = 20.8, 13.2, 7.7 Hz, 1H), 3.33 (s, 1H), 
1.20 (t, J = 7.0 Hz, 1H). 13C NMR (100 MHz, MeOD) δ 142.95, 129.42, 128.92, 127.66, 
74.80, 70.97, 63.01.  
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 (1S,2S)-2-azido-1-phenylpropane-1,3-diol (191). Oil. [α]25D 
+76.60 (c =1, CHCl3); 1H NMR (400 MHz, MeOD) δ 7.49 – 7.35 
(m, 4H), 7.31 (t, J = 7.0 Hz, 1H), 4.74 (d, J = 6.0 Hz, 1H), 3.58 (dt, J 
= 6.7, 3.6 Hz, 2H), 3.48 (ddd, J = 20.7, 13.2, 7.7 Hz, 1H), 3.33 (s, 1H). 13C NMR (101 
MHz, MeOD) δ 142.96, 129.42, 128.92, 127.67, 74.81, 70.98, 63.02. 
 
General procedure for modified Sandmeyer (bromination) reaction. 
To a solution of aminoarene (5.0 mmol) in a mixture of 25 mL of DMSO and KNO2 
(1.70 g, 20 mmol) was added dropwise a solution of 47% HBr (2.49 mL, 20 mmol) and 
KI (4.15 g, 25 mmol) dissolved in DMSO (25 mL) at 35 °C. When the addition was 
complete, the mixture was further stirred for an additional 10 min at 35 °C and then 
transferred to a solution containing K2CO3 (5 g) in 100 mL ice water. The reaction 
mixture was added to a volume of diethyl ether, and the ethereal extracts were washed 
with water and dried over anhydrous magnesium sulfate. Removal of the solvent under 
reduced pressure afforded the crude product. 
 
General procedure for Sandmeyer (bromination) reaction. 
An aqueous solution of NaNO2 (1.27 g, 18.85 mmol, 50 ml H2O) was added dropwise to 
a solution of aminoarene (3.76 g, 16.8 mmol) in 35 ml of 48% aqueous HBr at 0 oC. After 
addition was complete, the mixture was stirred for 30 min at 0 0C. The mixture was then 
added dropwise to a solution of CuBr (2.65g, 18.45 mmol) in 15 ml 48% aqueous HBr. 
The mixture was warmed to room temperature and stirred for additional 16 hours. The 
reaction mixture was neutralized with 3 M aqueous NaOH, filtered through a pad of 
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Celite, and extracted with EtOAc (3 x 100 mL). The combined organic fractions were 
dried over anhydrous Na2SO4 and concentrated to give 1.2 g (4.17 mmol) of crude 
product.   
 (1R,2R)-2-azido-1-(4-bromophenyl)propane-1,3-diol (155).  
Oil. [α]25D -74.50 (c =1, CHCl3); 1H NMR (400 MHz, d6-
acetone) δ 7.58 – 7.51 (m), 7.42 (d, J = 8.4 Hz), 4.92 (d, J = 4.4 
Hz), 4.24 (s), 3.75 (dd, J = 10.7, 3.3 Hz), 3.62 (d, J = 6.8 Hz), 3.57 (dd, J = 7.9, 3.2 Hz), 
3.06 (s), 2.57 (s). 13C NMR (100 MHz, d6-acetone) δ 141.84, 131.11, 128.65, 120.81, 
72.69, 69.00, 61.82.  HRESI+MS: (C9H10BrN3O2Na) Calc: 293.9854. Found: 293.9860. 
 
(1R,2R)-2-azido-1-(4-bromophenyl)propane-1,3-diol (168).  
Oil. [α]25D +78.00 (c =1, CHCl3); 1H NMR (400 MHz, d6-
acetone) δ 7.58 – 7.51 (m), 7.42 (d, J = 8.4 Hz), 4.92 (d, J = 4.4 
Hz), 4.24 (s), 3.75 (dd, J = 10.7, 3.3 Hz), 3.62 (d, J = 6.8 Hz), 3.57 (dd, J = 7.9, 3.2 Hz), 
3.06 (s), 2.57 (s). 13C NMR (100 MHz, d6-acetone) δ 141.84, 131.11, 128.65, 120.81, 
72.69, 69.00, 61.82.   
 
General procedure for Sandmeyer (cyanation) reaction. 
To the aminoarene (10.26 g, 49 mmol) was added concentrated HCl (26 mL) and H2O 
(130 mL) at room temperature, and then cooled to 0oC. The resulting suspension was 
diazotized at 0 to 5 oC with NaNO2 (3.7 g, 53 mmol) in H2O (20 mL). After stirring for 
30 minutes at 0 oC, the mixture was added to a solution of CuCN (9.23 g, 0.085 mol) and 
KCN (16.6g, 0.255 mol) in H2O (80 mL). The mixture was vigorously stirred at 0 oC for 
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1 hour and then warmed to 50 oC. After cooling, the mixture was extracted with EtOAc. 
The organic phase was washed with 1 M NaOH (90 mL), H2O (90 mL), dried over 
Na2SO4 and evaporated. Silica gel column chromatography (EtOAc:hexanes 1:1) yielded 
the nitrile product.   
 
 4-((1R,2R)-2-azido-1,3-dihydroxypropyl)benzonitrile (157).  
Oil. [α]25D -39.59 (c =0.5, CHCl3); 1H NMR (400 MHz, d6-
acetone) δ 7.78 (d, J = 8.3 Hz), 7.68 (d, J = 8.2 Hz), 5.13 (d, J = 
4.7 Hz), 3.85 – 3.78 (m), 3.63 (ddt, J = 11.0, 6.7, 5.5 Hz), 3.13 (s). 13C NMR (100 MHz, 
d6-acetone) δ 147.97, 131.93, 127.52, 118.50, 111.13, 72.72, 68.59, 61.81. 
 
General Experimental Procedure for the Tosylation of 1,3-diols. 
 To a solution of diol (10 mmol) in DCM (20 mL) was added Bu2SnO (0.2 mmol), p-
TsCl (10 mmol), and Et3N (10 mmol). The reaction mixture was stirred until TLC 
indicated complete consumption of the starting material (8-12 hours). The mixture was 
filtered, and the filtrate was concentrated in vacuo. The residue was crystallized or 
purified using silica gel chromatography to afford the desired monotosylate.  
 
(2R,3R)-2-azido-3-(4-bromophenyl)-3 hydroxypropyl 4-
methylbenzenesulfonate (158). Oil. [α]25D -35.80 (c =1, 
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CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.78 (d, J = 8.2 Hz, 1H), 7.49 (dd, J = 8.1, 5.3 
Hz, 2H), 7.40 (d, J = 8.5 Hz, 1H), 7.34 (dd, J = 8.4, 4.3 Hz, 1H), 5.20 (dd, J = 4.6, 3.1 
Hz, 1H), 4.91 (dd, J = 10.9, 5.5 Hz, 1H), 4.17 (dd, J = 10.4, 3.2 Hz, 1H), 3.98 – 3.90 (m, 
1H), 3.89 – 3.82 (m, 1H), 3.40 (q, J = 7.0 Hz, 1H), 2.91 (s, 2H), 2.88 (s, 1H), 2.47 (s, 
2H). 
 
(2R,3R)-2-azido-3-(4-cyanophenyl)-3-hydroxypropyl 4-
methylbenzenesulfonate (160). Oil. 1H NMR (400 MHz, d6-
acetone) δ 7.82 (d, J = 8.2 Hz), 7.72 (d, J = 8.2 Hz), 7.63 (d, J 
= 8.2 Hz), 7.47 (d, J = 8.1 Hz), 5.32 (d, J = 4.8 Hz), 4.30 (dd, J = 10.5, 3.5 Hz), 4.07 (dd, 
J = 10.4, 7.5 Hz), 3.99 – 3.93 (m), 2.46 (s). 13C NMR (101 MHz, d6-acetone) 146.54, 
145.51, 132.61, 132.18, 130.17, 127.95, 127.51, 118.50, 111.57, 72.50, 69.30, 65.34, 
20.89. 
 
 (2R,3R)-2-azido-3-(4-azidophenyl)-3-hydroxypropyl 4-
methylbenzenesulfonate (162). Oil. [α]25D -60.59 (c =1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 
1H), 7.35 (d, J = 8.1 Hz, 1H), 7.30 (d, J = 8.4 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 4.75 (d, 
J = 5.6 Hz, 1H), 4.16 – 4.09 (m, 1H), 3.91 (dd, J = 10.5, 6.7 Hz, 1H), 3.72 (td, J = 6.3, 
4.4 Hz, 1H), 2.65 (s, 1H), 2.46 (s, 2H), 2.03 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 
145.51, 140.55, 136.07, 132.35, 130.12, 128.09, 127.91, 119.47, 72.83, 68.64, 65.74, 
21.79. 
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Attempted Synthesis of 152 by Selective Reduction of Nitro Aromatic 149 
Method 1.  The nitro derivative 149 (200 mg) was dissolved in THF (10 mL) and water 
(4 mL) was added. To this stirring mixture was added sodium dithionite (310 mg), and 
this was stirred at room temperature for 2 h. The solution was warmed to 40oC for 10 min 
and then allowed to cool to room temperature. Another portion of sodium dithionite (150 
mg) was added and stirring was continued for another 3 h. The reaction was monitored by 
TLC (acetone: chloroform; 1:1). After the reaction was complete, the solvent was 
evaporated and the residue purified by silica gel column chromatography. The product 
was isolated but contained significant contaminants. 
Method 2.  An aqueous solution (20 ml) containing K2CO3 (4.15 g, 30 mL) and Na2S2O4 
(4.70 g, 27 mmol) was added dropwise to a mixture of nitroarene 149 (6 mmol) and 
viologen (0.162 g, 0.3 mmol) in DCM (40 mL) and water (5 mL) under an inert 
atmosphere of argon. Stirring was continued for 2-8 h at 35oC and then the aqueous layer 
was extracted with DCM (3 X 20 mL). The combined organic layers were dried, and 
treated with silica gel to remove any remaining viologen species. TLC analysis showed 
the same profile when compared to the reaction performed with Na2S2O4.  
Method 3.  The nitro derivative 149 (238 mg, 1mmol) was treated with 606 mg of Na2S 
in absolute EtOH. The reaction was monitored by TLC and presented the same profile on 
the other two previous methodologies, but appeared to contain less side products.  
 
(1R,2S)-2-amino-1-(4-aminophenyl)propane-1,3-diol (153).  
A 2 l round bottom flask was charged with 47.86 g of compound 
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148, absolute ethanol and 7.17 g of Pd/C. After stirring for 5 minutes, vacuum was 
applied to the round bottom flask and a volume of hydrogen gas was introduced. The 
reaction was stirred at room temperature and monitored with TLC. The reduction was 
complete after 4 days.  The reaction was filtered and the Pd/C recovered. The ethanol was 
evaporated and the residue recrystallized from ethanol to afford 153 in 90% yield. 
Procedures for the synthesis of oxetanes. 
Method 1.  (K-tert-butoxide). 3.21g of tosylated precursor was dissolved in anhydrous 
THF (75 mL) and anhydrous benzene (75 mL).  Potassium tert-butoxide (1.26 g) was 
added, and the mixture brought to reflux. Complete consumption of starting material was 
evident after an excess of base was added (1.5 additional equivalents). After cooling to 
room temperature, the reaction mixture was quenched with water and extracted with 
EtOAc, dried over sodium sulfate and evaporated. The crude residue was purified by 
silica gel chromatography [hexane:EtOAc gradient (100:0 to 60:40)] and homogenous 
product bands characterized. 
Method 2 (Potassium carbonate) To a solution of tosylated precursor (130 mg) in 
MeOH (20 mL) was added K2CO3 (52 mg) at 0 °C and allowed to warm to room 
temperature.  This stirred for 5 days with TLC monitoring. After completion, the 
methanol was removed under reduced pressure and the residue was purified using silica 
gel column chromatography.   Yield of oxetane products ranged from 70-90%.  
 
 (2R,3R)-3-azido-2-(4-nitrophenyl)oxetane (151). Oil. [α]25D -
68.38 (c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 8.25 (d, J = 
O2N
N3
O
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9.0 Hz, 2H), 7.75 (d, J = 9.0 Hz, 1H), 5.49 (d, J = 4.7 Hz, 1H), 5.13 (t, J = 4.6 Hz, 1H), 
3.83 (m, 1H), 3.63 (dd, J = 13.0, 4.1 Hz, 1H), 3.46 (dd, J = 13.0, 7.9 Hz, 1H). 13C NMR 
(100 MHz, d6-acetone) δ 150.15, 128.62, 124.18, 100.88, 73.99, 67.35, 52.40. 
 
 (2R,3R)-3-azido-2-(4-bromophenyl)oxetane (159). Oil. [α]25D -
23.10 (c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.3 
Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.90 (d, J = 6.6 Hz, 1H), 4.99 (t, J 
= 7.0 Hz, 1H), 4.77 (dd, J = 12.1, 6.2 Hz, 1H), 4.60 – 4.52 (m, 1H). 13C NMR (101 MHz, 
CDCl3) δ 135.80, 131.64, 128.03, 122.56, 86.07, 74.10, 57.97. 
 
(2R,3S)-3-azido-2-(4-bromophenyl)oxetane (175). Oil. [α]25D +13.79 
(c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.4 Hz, 2H), 
7.30 (d, J = 8.3 Hz, 2H), 5.57 (d, J = 6.0 Hz, 1H), 4.76 (t, J = 7.1 Hz, 
1H), 4.63 (t, J = 6.8 Hz, 1H), 4.28 (dd, J = 13.5, 6.8 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 138.63, 131.95, 126.95, 122.66, 88.04, 72.72, 61.56. 
 
 4-((2R,3R)-3-azidooxetan-2-yl)benzonitrile (161). Oil. [α]25D -
24.10 (c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.84 (d, J = 
8.3 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H), 6.11 (d, J = 6.7 Hz, 1H), 5.10 
(dd, J = 11.7, 6.7 Hz, 1H), 5.02 (t, J = 7.0 Hz, 1H), 4.50 (dd, J = 6.6, 5.0 Hz, 1H). 13C 
NMR (101 MHz, d6-acetone) δ 148.64, 147.60, 132.83, 128.34, 119.27, 112.08, 100.15, 
73.90. 
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4-((2S,3S)-3-azidooxetan-2-yl)benzonitrile (173). Oil. [α]25D +25.20 
(c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.84 (d, J = 8.3 Hz, 
1H), 7.66 (d, J = 8.0 Hz, 1H), 6.11 (d, J = 6.7 Hz, 1H), 5.10 (dd, J = 
11.7, 6.7 Hz, 1H), 5.02 (t, J = 7.0 Hz, 1H), 4.50 (dd, J = 6.6, 5.0 Hz, 1H). 13C NMR (101 
MHz, d6-acetone) δ 148.64, 147.60, 132.83, 128.34, 119.27, 112.08, 100.15, 73.90. 
 
4-((2R,3S)-3-azidooxetan-2-yl)benzonitrile (177). Oil. [α]25D +19.80 
(c =1, CHCl3); 1H NMR (400 MHz, d6-acetone) δ 7.85 (d, J = 8.3 Hz, 
2H), 7.69 (d, J = 8.2 Hz, 2H), 5.70 (d, J = 5.5 Hz, 1H), 4.90 – 4.82 (m, 
1H), 4.65 – 4.57 (m, 2H). 13C NMR (101 MHz, d6-acetone) δ 148.64, 147.60, 132.83, 
128.34, 119.27, 112.08, 100.15, 73.90. 
 
 (2R,3R)-3-azido-2-(4-azidophenyl)oxetane (163). Oil. [α]25D -
30.39  (c =1, CHCl3);1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.4 
Hz, 2H), 7.09 (d, J = 8.4 Hz, 2H), 5.91 (d, J = 6.6 Hz, 1H), 4.96 (t, J 
= 7.0 Hz, 1H), 4.75 (dd, J = 11.9, 6.5 Hz, 1H), 4.53 (dd, J = 7.1, 5.2 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) δ 140.17, 133.41, 127.92, 118.98, 86.07, 73.88, 58.11. 
 
 (2S,3S)-3-azido-2-(4-bromophenyl)oxetane (170). Oil. [α]25D 
+22.00 (c =1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.3 
Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.90 (d, J = 6.6 Hz, 1H), 4.99 (t, J 
= 7.0 Hz, 1H), 4.77 (dd, J = 12.1, 6.2 Hz, 1H), 4.60 – 4.52 (m, 1H). 
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(2R,3R)-3-azido-2-phenyloxetane (179). Oil. [α]25D -38.40 (c =1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.35 (m, 3H), 5.97 
(d, J = 6.7 Hz, 1H), 5.00 (t, J = 7.0 Hz, 1H), 4.78 (dd, J = 11.9, 6.7 Hz, 1H), 4.59 (dd, J = 
6.9, 5.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 136.74, 128.50, 128.45, 126.31, 86.65, 
73.96, 58.04. 
 
 (2S,3R)-3-azido-2-phenyloxetane (190). Oil. [α]25D 7.2 (c =1, 
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.50 (dd, J = 8.0, 1.1 Hz, 
2H), 7.44 (t, J = 7.4 Hz, 2H), 7.37 (ddd, J = 8.2, 2.6, 1.3 Hz, 1H), 5.59 (d, J = 5.7 Hz, 
1H), 4.79 (t, J = 6.6 Hz, 1H), 4.64 – 4.46 (m, 2H). 13C NMR (101 MHz, MeOD) δ 
139.76, 128.46 (x2C), 125.30, 88.81, 72.41, 61.46. 
 
(2S,3S)-3-azido-2-phenyloxetane (193). Oil. [α]25D +51.20 (c =1, 
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.62 – 7.26 (m, 6H), 
6.02 (d, J = 5.9 Hz, 1H), 5.08 – 4.89 (m, 2H), 4.58 – 4.40 (m, 1H). 13C NMR (100 MHz, 
d6-acetone)) δ 138.76, 129.06, 128.94, 127.31, 87.12, 74.30, 59.38. 
  
(2R,3S)-3-azido-2-phenyloxetane (195). Oil. [α]25D -6.4 (c =1, 
CHCl3); 1H NMR (400 MHz, d6-acetone)) δ 7.49 (dd, J = 8.0, 1.1 Hz, 
2H), 7.43 (t, J = 7.4 Hz, 2H), 7.36 (ddd, J = 8.2, 2.6, 1.3 Hz, 1H), 5.58 (d, J = 5.7 Hz, 
1H), 4.86 – 4.73 (m, 1H), 4.62 – 4.46 (m, 2H). 13C NMR (100 MHz, d6-acetone)) δ 
141.11, 129.45, 129.34, 126.41, 89.08, 73.08, 62.28. 
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4-((2R,3R)-3-aminooxetan-2-yl)benzonitrile (196). Oil. 1H NMR 
(400 MHz, MeOD) δ 7.82 (d, J = 8.3 Hz, 2H), 7.58 (d, J = 8.0 Hz, 
3H), 5.94 (d, J = 6.8 Hz, 1H), 5.08 – 4.97 (m, 1H), 4.46 – 4.34 (m, 
2H). 13C NMR (101 MHz, MeOD) δ 145.14, 133.38, 128.12, 119.76, 112.43, 89.15, 
79.63, 51.66. 
 
Attempted Grignard reactions of 159 with magnesium.  A solution of (2R,3R)-3-
azido-2-(4-bromophenyl)oxetane 159 (50 mg, 0.197 mmol) in anhydrous THF (10 mL) 
was added dropwise to magnesium turnings (5.91 mg) in anhydrous THF (20 mL) under 
an atmosphere of argon. A crystal of iodine was necessary to initiate the Grignard 
reaction. The reaction was refluxed for 2 h. The solvent was removed from the reaction 
mixture by rotary evaporation, and a solution of 161 (30 mg, 0.150 mmol) in anhydrous 
toluene (30 mL) was added slowly. The reaction mixture was refluxed for 12 h. An 
aliquot was taken from the reaction medium and quenched with NH4Cl, to observe the 
formation of (2R,3R)-3-azido-2-phenyloxetane (178) by LC-MS.   Only starting material 
remained. 
 
Attempted Grignard reactions of 159 with iPrMgCl-LiCl. 
Preparation of the reagent i-PrMgCl·LiCl: Magnesium turnings (110 mmol) and 
anhydrous LiCl (100 mmol) were placed in an Ar-flushed flask, and anhydrous THF (50 
mL) was added. A solution of iPrCl (100 mmol) in THF (50 mL) was slowly added at 
room temperature. The reaction started within a few minutes. After the addition, the 
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reaction mixture was stirred for 12 h at room temperature. The gray solution of 
iPrMgCl·LiCl was cannulated into another Ar-filled flask leaving behind excess Mg 
metal.  Reaction with arylbromide 159.  A flame-dried argon-flushed 10 mL flask, 
equipped with a magnetic stirrer and a septum, was charged with a solution of 159 (50 
mg) in anhydrous THF (0.2 mL). i-PrMgCl.LiCl (2.0 M/THF, 0.2 mmol, 1.1 equiv) was 
added slowly at -40 °C, and the resulting mixture was stirred at this temperature for 12 h 
to complete the bromine-magnesium exchange (checked by reaction of aliquots with 
NH4Cl).  Nitrile 161 (50 mg in 2 mL of THF, 1.1 equiv) was added. The mixture was 
warmed to room temperature and stirred for 12 hours.  This was quenched with saturated 
aqueous NH4Cl. Although the Mg insertion was confirmed, no product was observed 
with the addition of the benzonitrile. 
 
 (1R,2R)-1-(4-acetamidophenyl)-2-azidopropane-1,3-diyl 
diacetate (182). Oil. 1H NMR (400 MHz, MeOD) δ 7.59 (d, J 
= 8.5 Hz, 1H), 7.35 (d, J = 8.5 Hz, 1H), 5.81 (d, J = 7.3 Hz, 
1H), 4.10 (dq, J = 5.4, 3.7 Hz, 1H), 3.84 (td, J = 7.5, 1.9 Hz, 1H), 2.12 (s, 1H), 2.10 (s, 
2H), 2.04 (s, 1H). 13C NMR (100 MHz, MeOD) δ 170.59, 170.32, 169.89, 139.13, 
131.97, 127.38, 119.77, 74.98, 63.57, 62.89, 22.48, 19.47, 19.11. 
 
General Methodology for Misunobu Reactions. Diisopropylazodicarboxylate (DIAD) 
(0.07 mL, 0.45 mmol) was added to a solution of Ph3P (75 mg, 0.45 mmol) in anhydrous 
THF (5 mL) at 0oC under an inert atmosphere of argon. The solution was stirred for 15 
minutes. A solution of the tosylated alcohol in THF (5 mL) was added dropwise. The 
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resulting bright yellow solution was stirred for 15 min at 0 °C and then 4 h at room 
temperature. The reaction was monitored by TLC. The solvent was removed, and the 
residue purified by silica gel column chromatography with hexanes:EtOAc (97:3).  
 
 
(1R,2S)-2-azido-1-(4-bromophenyl)-3-(tosyloxy)propyl 4-
nitrobenzoate (174).  [α]25D 5.0 (c =1, CHCl3); 1H NMR (400 
MHz, d6-acetone) δ 8.45 – 8.34 (m, 4H), 8.30 (d, J = 8.9 Hz, 
2H), 7.78 (d, J = 8.3 Hz, 2H), 7.67 – 7.56 (m, 4H), 7.56 – 7.46 
(m, 3H), 7.42 (d, J = 8.1 Hz, 2H), 6.11 (d, J = 6.7 Hz, 1H), 
4.61 – 4.49 (m, 2H), 4.45 – 4.34 (m, 2H), 4.33 – 4.21 (m, 2H), 2.40 (s, 3H). 13C NMR 
(100 MHz, d6-acetone) δ 162.86, 151.09, 145.41, 135.36, 134.70, 131.75, 131.00, 130.04, 
129.48, 129.42, 127.85, 123.70 , 122.61, 74.50, 68.10, 62.91, 20.58. 
 
 (1S,2R)-2-azido-1-phenyl-3-(tosyloxy)propyl 4-nitrobenzoate 
(189).  [α]25D -9.57 (c = 1.0, CHCl3) IR (CHCl3,) ν 2117, 1734, 1600, 
1530, 1267, 1178, 1099. 1H NMR (400 MHz, CDCl3) δ 8.22 (dd, J = 
28.9, 8.9 Hz, 4H), 7.76 (d, J = 8.3 Hz, 2H), 7.36 (ddd, J = 24.5, 13.7, 
5.8 Hz, 8H), 6.08 (d, J = 6.0 Hz, 1H), 4.23 (td, J = 6.3, 4.4 Hz, 1H), 
4.17 (dd, J = 10.5, 4.3 Hz, 1H), 4.15 – 4.08 (m, 1H), 2.40 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 163.08, 150.78, 145.50, 134.82, 132.14, 130.95, 130.05, 129.41, 128.94, 
127.98, 127.18, 126.49, 123.63, 75.57, 67.63, 63.11, 21.02. 
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(1R,2S)-2-azido-1-phenyl-3-(tosyloxy)propyl 4-nitrobenzoate 
(194).  [α]25D +12.65 (c = 1.0, CHCl3) IR (CHCl3,) ν 2117, 1734, 
1600, 1530, 1267, 1178, 1099. 1H NMR (400 MHz, CDCl3) δ 8.22 
(dd, J = 28.9, 8.9 Hz, 4H), 7.76 (d, J = 8.3 Hz, 2H), 7.36 (ddd, J = 
24.5, 13.7, 5.8 Hz, 8H), 6.08 (d, J = 6.0 Hz, 1H), 4.23 (td, J = 6.3, 
4.4 Hz, 1H), 4.17 (dd, J = 10.5, 4.3 Hz, 1H), 4.15 – 4.08 (m, 1H), 2.40 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ 163.08, 150.8, 145.50, 134.82, 132.14, 130.95, 130.05, 129.41, 
128.94, 127.98, 127.18, 126.49, 123.63, 75.57, 67.63, 63.11, 21.02. 
 
 (1R,2S)-2-azido-1-(4-cyanophenyl)-3-(tosyloxy)propyl 4-
nitrobenzoate (176). [α]25D +34.59 (c = 1.0, CHCl3); 1H 
NMR (400 MHz, , d6-acetone) δ 8.35 (dd, J = 20.3, 9.0 Hz, 
4H), 7.80 (dd, J = 14.4, 8.2 Hz, 6H), 7.42 (d, J = 8.0 Hz, 
2H), 6.20 (d, J = 6.7 Hz, 1H), 4.61 (td, J = 6.5, 3.5 Hz, 1H), 
4.42 (dd, J = 10.9, 3.5 Hz, 1H), 4.31 (dd, J = 10.9, 6.3 Hz, 1H), 2.41 (s, 3H). 13C NMR 
(101 MHz, Acetone) δ 162.90, 159.52, 156.35, 156.31, 145.47, 141.17, 134.45, 132.56, 
131.07, 130.07, 128.37, 127.86, 123.67, 112.80, 74.46, 68.31, 62.82, 21.34. 
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